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16S rDNA PCR:  16S rRNA gene realtime PCR  
AFB:   Acid-fast bacillus 
ARNr 16S :  S16 ribosomal RNA 
BCG:  Bacille Calmette-Guérin 
CAS:   Central-Asian 
CDS:   Coding Sequence  
CR3:   Complement receptor 3 
CSF:    Cerebral spinal fluid  
CTAB:    Cetyltrimethyl Ammonium Bromide  
CTL:     Cytolytic T lymphocytes  
DC:     Dendritic cells  
DC-SIGN: Dendritic cell-specific intercellular-adhesion molecule-
3-grabbing non-integrin 
DIP:    Deletion Insertion Polymorphism 
DST:    Drug susceptibility testing  
EAI :   East African-Indian  
EMB:  Ethambutol 
ETR-A:   Extract tandem repeat A  
GM-CSF:    Granulocyte-macrophage colony-stimulating factor 
IFN:   Interferon 
IS6110:   Insertion sequence 6110 
ISC:    Indian Subcontinent 
katG:   catalase-peroxidase  
LAM :   Latin American and Mediterranean 
LSP:    Large Sequence Polymorphisms 
MDR:   Multidrug-resistant  
MDR-TB:   Multidrug-resistant tuberculosis 
MHC:    Major histocompatibility complex  
MIRU:   Mycobacterium Intespersed Repetitive Units 
MMR:   Macrophage mannose receptor 
MODS:   Microscopic-Observation Drug-Susceptibility  
MDR-TB:   Multi-drug resistant tuberculosis  
NaOH-NALC:  N-acetyl-L-cysteine  
NCBI :    NationalCenter for Biotechnology Information  
NK:    Natural killer  
OADC:   Oxalic acid, albumin, dextrose, and catalase 
ORF:    Open reading frame  
PANTA:  Polymyxin, Amphotericin B, Nalidixic Acid, 
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PBS:  Phosphate buffered saline  
PCR:  Polymerase Chain Reaction 
PE :   proline-glutamate 
PGRS:     Polymorphic GC-rich sequences  
PMN :   Polymorphonuclear neutrophils  
PPE:    Proline-Proline-Glutamate 
RD:     Direct Repeat 
RFLP:  Restriction fragment length polymorphism 
rpoB:   β subunit of DNA dependant RNA polymerase 
rRNA gene:   gene coding ribosomal RNA    
SIT:    Spoligo-international type  
SNP:    Single-nucleotide polymorphism 
ST:    shared type 
STR:   Streptomycin 
TB:    Tuberculosis 
TDM:    Trehalose 6, 6’-dimycolate  
TGF:    Transforming growth factor 
TGF-β:   Transforming growth factor-β  
TLR:    Toll-like receptors  
TM cells:     Memory T cell 
TNF:   Tumour necrosis factor. 
Treg:    Regulatory T   
tRNA gene:  Gene coding transfer RNA 
VDR:   Vitamin D receptor  
VNTR:   Variable numbers of tandem repeats 
WHO:   World Health Organization 
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 The overall objective of this study is to determine molecular 
epidemiology and phenotypic and genetic characterization of mycobacteria 
isolated in central Vietnam. 
In this study,  the MODS assay was used to isolate mycobacteria and 
determine the proportion of drug resistant strains in 252 clinical samples. 
M.tuberculosis was detected in153 samples (60.7%) and 46 (30.1%) were 
antibiotic resistant. One drug resistance was present in 30 strains (19.6%): 18 
for RIF, 6 for INH and 3 for STR and  EBM. Multidrug resistant 
M.tuberculosis as defined by WHO (resistant to RIF and INH) was observed 
in 13 strains. There were additional 14 strains showing resistance to two or 
more drugs. 
Identification of M.tuberculosis using the 16S rDNA based PCR assay 
detected 258 positive in 480 clinical samples(53.8%), including 73 smear 
negative cases. The IS6110 PCR of positive cases could not confirm the 
positivity in 3 samples, probably due to the absence of the insertion sequence. 
Spoligotyping produced a total of 36 different patterns for the 122 
M.tuberculosis strains examined. The EAI family genotype (65.6% of 
isolates) dominated in our study: 15.6 % were of the EAI4-VNM genotype 
and 46.7 % were of EAI5. Beijing genotype was observed in 12.3 % of 
isolates. There were 4 isolates (3.3%) in which spoligotype pattern did not 
match with any of the updated international spoligotype database of the 
M.tuberculosis complex - SpolDB4. The remaining 22% were  of other 
genotypes (including U, T, MANU, H and CAS).  
Sequence and analysis of the whole genome of MTB_HUE_20 strain - 
a multidrug resistant strain with unknown spoligotype pattern - showed that 
it is 4,397,928 bp in length and contains 64.8% of GC. This strain harbors 




Ngo Viet Quynh Tram - Molecular epidemiology and phenotypic and genetic characterization of 
Mycobacteria isolated in central Vietnam - Ph.D thesis in Clinical and Molecular Microbiology 






2.1. Epidemiology of tuberculosis 
2.1.1.Global burden of tuberculosis 
The consequences of tuberculosis (TB) on human society are immense. 
Worlwide, one person out of three is infected with Mycobacterium tuberculosis 
– two billion people in total. TB accounts for 2.5% of the global burden of 
disease and is the commonest cause of death in young women, killing more 
women than all causes of maternal mortality combined. TB currently holds the 
seventh place in the global ranking of causes of death.
177,210
 
Effective drugs to treat and cure the disease have been available for 
more than 50 years, yet every 15 seconds, someone in the world dies from 
TB. Even more alarmingly a person is newly infected with Mycobacterium 
tuberculosis every second of every day. Left untreated, a person with active 
TB will infect an average of 10 to 15 other people every year.
66
 
TB hinders socioeconomic development: 75% of people with TB are 
within the economically productive age group of 14-54 years. 95% of all 
cases and 99% of deaths occur in developing countries, with the greatest 




World Health Organization (WHO) estimated 8.9 million new cases of 
TB in 2004 (140/100,000 population). About 3.9 million cases (92/100,000 
population) were acid fast bacilli (AFB) sputum smear-positive, the most 
infectious form of the disease. There were 14.6 million prevalent case 




In 2009, there were an estimated 9.4 million incident cases (range, 8.9 
million–9.9 million)1 of TB globally (equivalent to 137 cases per 100,000 
population) (table1, figure 1). The absolute number of cases continues to 
increase slightly from year to year, as slow reductions in incidence rates per 
capita continue to be outweighed by increases in population. Most of the 
estimated number of cases in 2009 occurred in Asia (55%) and Africa 
(30%)(Asia here means the WHO regions of South-East Asia and the 
WesternPacific. Africa means the WHO African Region); smaller 
proportions of cases occurred in the Eastern Mediterranean Region (7%), the 
European Region (4%) and the Region of the Americas (3%). The 22 highest 
burden countries (HBCs) that have received particular attention at the global 
level since 2000 account for 81% of all estimated cases worldwide (Table 1). 
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The five countries with the largest number of incident casesin 2009 were 
India (1.6–2.4 million), China (1.1–1.5 million), South Africa (0.40–0.59 
million), Nigeria (0.37–0.55 million) and Indonesia (0.35–0.52 million). 
India alone accounts for an estimated one fifth (21%) of all TB cases 
worldwide, and China and India combined account for 35%.
267
 
Of the 9.4 million incident cases in 2009, an estimated 1.0–1.2 million 
(11–13%) were HIV-positive, with a best estimate of 1.1 million (12%) 
(table 1, figure 2). These numbers are slightly lower than those reported in 
previous years, reflecting better estimates as well as reductions in HIV 
prevalence in the general population. Of these HIV-positive TB cases, 
approximately 80% were in the African Region.
267
 
There were an estimated 14 million prevalent cases (range, 12 




In 2009, an estimated 1.3 million deaths (range, 1.2 million–1.5 
million) occurred among HIV-negative cases of TB (table 1). This is 
equivalent to 20 deaths per 100,000 population. In addition, there were an 
estimated 0.4 million deaths (range, 0.32 million – 0.45 million) among 
incident TB cases that were HIV-positive (data not shown); these deaths are 
classified as HIV death in the 10th revision of the International Classification 
of Diseases (ICD-10). Thus in total, approximately 1.7 million people died 
of TB in 2009. The number of TB deaths per 100,000 population among 
HIV-negative people plus the estimated number of TB deaths among HIV-




The emergence of drug resistance strains of Mycobacterium 
tuberculosis and particularly multidrug-resistant M.tuberculosis strains, has 
become a significant public health problem in a number of countries and an 
obstacle for an effective control of tuberculosis (TB).  More than 400,000 
cases of MDR-TB emerge every year as a result of under investments in 
basic activities, poor management of patients that results in the transmission 
of the deadly strains.  Despite its global magnitude, the problem has not been 
addressed adequately. MDR-TB has been a topic of growing interest.  MDR-
TB are much more difficult and costly to treat than drug-susceptible TB, 
since more than 2 year of therapy may be required to treat a patient infected 
with MDR-TB strains compared with the 6-8  months required to treat those 
infected with a sensitive strains. As a results of long lasting treatment and the 
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Table1: Estimated epidemiological burden of TB, 2009 ( From WHO, 2010) 




























- Indicates no data reported. 
a 
Numbers for mortality, prevalence and incidence shown to two significant figures. 
Totals for HBCs and global computed prior to rounding using Monte Carlo 
simulations. 
b 
Mortality excludes deaths among HIV-positive case. Deaths among HIV-positive TB 
cases are classified as HIV deaths according to ICD-10. 
c 
Best, low and high indicate best estimates followed by lower and upper bounds. The 




 centiles of outcome 
distributions produced in simulations. 
d 
Banladesh completed a survey of the prevalence of TB disease in 2009. A reassessment 
of the epidemiological burden of TB, using data from the survey combined with an 
in-depth anlysis of surveillance and programmatic data, will be undertaken in 2011.  
e 
Myanmar completed a survey of the prevalence of TB disease in 2010. A reassessment 
of the epidemiological burden of TB will be undertaken finalization and 
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Figure 1: Estimated TB incidence rates, by country, 2009 (FromWHO, 2010) 
 
MDR-TB most commonly develops in the course of TB treatment, and 
is most commonly due to doctors giving inappropriate treatment, or patients 
missing doses or failing to complete their treatment. It has been proposed 
that MDR-TB strains appear to be less fit and less transmissible, and 
outbreaks tend to occur in people with weakened immune systems (e.g., 
patients with HIV), although outbreaks among immunocompetent people do 
occur and the number of cases of TB due to MDR-TB on the rise. A 1997 
survey of 35 countries found rates above 2% in about a third of the countries 
surveyed. The highest rates were in the former USSR, the Baltic states, 




There were an estimated 440,000 cases of multi-drug resistant TB 
(MDR-TB) in 2008 (range, 390,000–510,000). The 27 countries (15 in the 
European Region) that account for 86% of all such cases have been termed 
the 27 high MDR-TB burden countries. The four countries that had the 
largest number of estimated cases of MDR-TB in absolute terms in 2008 
were China (100,000; range, 79,000-120,000), India (99,000; range, 79,000–
120,000), the Russian Federation (38,000; range, 30,000–45,000) and South 
Africa (13,000; range 10,000–16,000). By July 2010, 58 countries and 
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2.1.2.  TB burden in Vietnam 
The Viet Nam National Tuberculosis Control Programme (NTP) is 
based on the principles of DOTS, the core control strategy recommended by 
the World Health Organization (WHO). According to WHO estimates, since 
1997 Viet Nam has reached and exceeded the global targets for tuberculosis 
control
98,252
 i.e. to detect >70% of new smear-positive pulmonary 
tuberculosis cases and cure >85% of these detected cases.
266
 If these targets 
were met, tuberculosis incidence in Viet Nam would predictably have 
decreased over the period 1997–2004 by 44%.64,252 Although there was 
indeed a small decrease in tuberculosis notification rates among women and 
persons older than 35 years, this was offset by an increase among young 
men, which led to stabilization in notification rates during this period.
128
 
In Vietnam, almost 30,000 people die every year (one death every 18 
minutes) from TB. Vietnam ranks 12th among the 22 countries
262
 which 
added together account for 80% of the global TB burden, with a prevalence 
of smear-positive tuberculosis of 89 per 100,000 population (WHO, 
unpublished data, 2008). If TB is detected early and properly treated using a 
combination of medicines for 6 to 9 months, the patients quickly become 
non-infectious and are eventually cured. Multi-drug resistant TB (MDR-TB) 
and extensively drug-resistant TB (XDR-TB), HIV-associated TB and weak 
health systems are major challenges in Viet Nam. There are an estimated 
7,000 new MDR-TB cases and 6,400 new TB/HIV cases every year. Both of 
these forms of complicated TB carry a high risk of early mortality.
262 
 
2.2. Bacteriology of Mycobacterium tuberculosis 
2.2.1. The bacillus 
Bacteria of the genus Mycobacterium are non-motile and non-sporulated 
rods. They are grouped in the suprageneric rank of actinomycetes that, 
unusually, have a high content (61-71 %) of guanine plus cytosine (G+C) in 
the genomic desoxyribonucleic acid (DNA), and a high lipid content in the 
wall, probably the highest among all bacteria. Mycobacterium and other 
closely related genera (i.e. Corynebacterium,Gordona, Tsukamurella, 
Nocardia, Rhodococcus and Dietzia) have similar cell wall compounds and 
structure, and hence show some phenotypic resemblance. Several mycolic 
acids in the envelope structure distinguish the mycobacteria. These quirky 
lipids may act as carbon and energy reserves. They are also involved in the 
structure and function of membranes and membranous organelles within the 
cell. Lipids constitute more than half of the dry weight of the mycobacteria. 
However, the lipid composition of the tubercle bacillus may vary during the 
life cycle in culture, depending on the availability of nutrients. The waxy coat 
confers the idiosyncratic characteristics of the genus: acid fastness, extreme 
hydrophobicity, resistance to injury, including that of many antibiotics, and 
distinctive immunological properties. It probably also contributes to the slow 
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growth rate of some species by restricting the uptake of nutrients.
177
 
Comprised within the M. tuberculosis complex and generically called 
the tubercle bacillus, the various etiologic agents of tuberculosis (TB) have 
distinct hosts, zoonotic potential and reservoirs (table 2). M. tuberculosis, 
and the regional variants or subtypes Mycobacterium africanum and 
“Mycobacterium canettii” are primarily pathogenic in humans. 
Mycobacterium bovis and Mycobacterium microti are the causative agents of 
TB in animals, and can be transmitted to humans. Some particular strains 
isolated from goats and seals have been named Mycobacterium caprae and 
Mycobacterium pinnipedi, although sometimes they are identified as M. 
bovis subspecies or variants. It could be expected that the major evolutive 
shifts involved in adaptation to different hosts would have entailed 
significant microbiological differentiation.
177
 However, the above mentioned 
agents of TB together with the vaccine bacille Calmette-Guérin (BCG) 




Table 2: Members of M. tuberculosis complex with specific names 













The microscopic appearance does not allow the differentiation of the 
pathogenic agents of TB, mainly M. tuberculosis, from other mycobacteria 
although some characteristics may be indicative. In smears stained with 
carbol fuchsin or auramine and examined under light microscope, the 
tubercle bacilli typically appear as straight or slightly curved rods. According 
to growth conditions and age of the culture, bacilli may vary in size and 
shape from short coccobacilli to long rods. 
By microscopic observation, Robert Koch first described the 
arrangement of bacilli in braided bunches and associated this phenomenon 
with virulent strains of M. tuberculosis. He also detailed the aspect of 
cultures in blood serum as compact scales which could be easily detached. In 
general, fresh virulent M. tuberculosis bacilli produce rough textured 
colonies on solid media, expanded gummy veils on the surface of liquid 
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media and serpentines on microscopic smears. In contrast, non-virulent 
mycobacteria and tubercle bacilli attenuated by prolonged cultures usually 
develop smooth colonies on solid media, form discrete mats in liquid media 
and distribute randomly in loose aggregates when smeared. The recognition 
of these two peculiarities, cording and crumbly colony formation, provides a 
reliable and timely clue to the experienced microbiologist for the 
presumptive distinction of M. tuberculosis from other mycobacteria in 
cultured specimens and even in sputum smears.
177
 
When numerous and actively multiplying, the bacilli are strongly acid 
fast and show an evident and distinctive tendency to form hydrophobic 
bundles (Figure 2-aand 2-b). Free bacilli can also be seen, though, especially 
at the border of the swarms. In unlysed host tissue, the bacilli are more 




Figure 2: Mycobacterium tuberculosis growing in culture (From Palomino et al., 2007) 
Ziehl-Neelsen staining at 1000x magnification. 
Electron microscopy at 20000x magnification 
 
These distinctive characteristics of the virulent bacilli have been 
attributed to the trehalose 6, 6‟-dimycolate (TDM). This compound, also 
known as cord factor, was described as an extractable glycolipid consisting 
of two mycolic acid molecules loosely bound in the outer layer of the cell 
wall.
170
 A myriad of biological activities related to pathogenicity, toxicity, 
and protection against the host response have been attributed to this 
molecule. However, it does not seem to be essential for bacterial 
multiplication in vitro.
99
 Several models were used to identify the role of the 
TDM in the microscopic and macroscopic morphology of M. tuberculosis. In 
this way it was demonstrated that beads coated with this substance generate 




The tubercle bacillus is prototrophic (i.e. it can build all its components 
from basic carbon and nitrogen sources) and heterotrophic (i.e. it uses already 
synthesized organic compounds as a source of carbon and energy). The 
microorganism macromolecular structure and physiological (metabolic) 
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nutritional quality of the environment determines the bacillus lifestyle and 
limitations, either in the natural habitat or in culture media, as do various 
physical conditions such as oxygen availability, temperature, pH and salinity.
177
 
As the environment changes, the bacillus is able to bring into play 
different physiological pathways in order to survive even in harsh conditions. 
This is a highly resourceful strategy, not only for pathogenicity but also for 
species persistence. It has been shown that, during the course of infection in 
mice, M. tuberculosis metabolism may shift from an aerobic, carbohydrate-
metabolizing mode to one that is more microaerophilic and utilizes lipids. 
These demonstrations, which were reported a long time ago, were supported 
in recent times by the completese quencing of the M. tuberculosis genome in 
which an unusually high number of genes putatively involved in fatty acid 
metabolism were identified. This phenomenon may be related to the ability 
of the pathogen to grow or persist in host tissues where fatty acids may be 
the major carbon source.
163
 
The tubercle bacillus requires oxygen as a final electron acceptor in 
aerobic respiration. Molecular oxygen is reduced to water in the last step of 
the electron transport system. In nature, the bacillus grows most successfully 
in tissues with high oxygen partial tension, such as the lungs, particularly the 
well-aerated upper lobes. Carbon dioxide is essential and may be taken from 
the atmosphere and also from carbonates or bicarbonates. In the laboratory, 
an atmosphere of 5 to 10 % carbon dioxide favors culture growth, at least 
during the early stage of incubation. On the other hand, M. bovis is 
microaerophilic, i.e. it grows preferentially at a reduced oxygen tension.
177
 
M. tuberculosis is mesophile and neutrophile as its multiplication is 
restricted to conditions offered by warm-blooded animals: about 37ºC and a 
neutral pH. The temperature and hydrogen ion concentration ranges, in 
which the bacillus is able to multiply, are relatively narrow. High saline 
concentration such as that found inmedia containing 5% sodium chloride, 
inhibits the growth of the microorganism.
177 
 
2.2.2. Immune response against tuberculosis 
The immune response against tuberculosis plays a fundamental role in 
the outcome of M. tuberculosis infection. It is clear that the immune system 
reacts efficiently in the vast majority of infections. This is particularly 
evident in the case of TB, where most people infected by the tubercle 
bacillus (~ 90 %) do not develop the disease throughout their life times. 
Nevertheless, the risk of developing the disease increases considerably when 
TB infection co-exists with an alteration in the immune system, such as co-
infection with human immunodeficiency virus (HIV).
177 
The likelihood and intensity of aerogenic transmission of M. tuberculosis 
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from a TB index case to a contact person in a shared air space depends on (i) 
exposure duration; (ii) intensity of exposure; (iii) cough and sputum-related 
host factors; and (iv) M.tuberculosis strain-related virulence characteristics. 
Infectious droplet nuclei are deposited in the alveolar spaces where M. 
tuberculosis can be phagocytosed by alveolar macrophages, epithelial cells, 
dendritic cells (DC) and neutrophils. Alveolar macrophages and DC are then 
believed to transport M. tuberculosis to local lymph nodes where T cells are 
primed and clonally expanded.
57
 
During active TB disease there is an exuberant local pulmonary 
immune response characterized by an alveolitis of activated a/b T-cell 
receptor-positive lymphocytes, recently recruited immature macrophages, 
193,201
 and strongly enhanced M.tuberculosis antigen-specific Th1 
responses,
95,202,228
 with large amounts of locally secreted IFN-γ. Increased 
numbers of alveolar neutrophils can also be found in subgroups of patients. 
M.tuberculosis-induced immune evasion mechanisms with production of 
suppressive cytokines and effector molecules may counteract protective 
immune responses and abrogate bactericidal immune mechanisms. The role 
of regulatory T (Treg) cells in suppressing local immune responses and 
probably permitting mycobacterial growth is not yet well understood.
57
 
Susceptibility to TB is associated with HIV-1 infection (decreased 
numbers and function of CD4+ and CD8+ T cells 
218,46
), therapeutic tumor 
necrosis factor-a (TNF-α) blockage,254 and hereditary IFN-γ and IL-12 
receptor abnormalities.
6
 These conditions have provided insights into 
immune requirements for protection against M. tuberculosis. However, 
because the potentially protective Th1responses (IFN-γ and TNF- α) are 
undermined in vivo by suppressive immune mechanisms, clear correlates of 
protection are still lacking for the assessment of new tuberculous vaccines 
and adjuvant immune therapies. 
A role for protective immune response also underlies the persistence of 
latent TB infection (a state assumed to exist in a third of humans worldwide) 
during which M. tuberculosis growth is suppressed. These non-replicating 
bacilli are characterized by intracellular lipid bodies
84
 and foamy lipid-laden 
macrophages may be associated with TB-related tissue pathology.
194
 
In the parenchymal tissue, M. tuberculosis may induce the formation 
of pathognomonic granulomas (inflammatory reaction characterized by a 
ball-likecollection of immune cells). Necrotizing granuloma centres
58
 
provide ideal culture conditions for M. tuberculosis that multiply 
extracellularly to large numbers, gain access to the airways and thus 
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Innate immunity to M. tuberculosis 
Upon entry into the host lungs by aerosol inhalation, M. tuberculosis 











nonintegrin, on the surface of macrophages and DC (Figure 3). These 
receptors recognize components of M. tuberculosis such as lipoprotein, CpG-
containingDNA, mannose-capped lipoarabinomannan and 
phosphatidylinositol mannoside, respectively. Lung surfactant protein D 
binds M. tuberculosis surface lipoarabinomannan and limits the intracellular 
growth of M. tuberculosis by increasing phagosome lysosome fusion.
74
 In 
addition, cytosolic nucleotide-binding and oligomerization domain-like 
receptors such as NOD2 that recognizes muramyl dipeptide
59
and also C-type 
lectin dectin-1 that interacts with M. tuberculosis cooperate with TLR-2 to 
activate NF-kBand mediate pro-inflammatory cytokine and antimicrobial 
responses. Toll NF-kB pathway activation promotes nucleus translocation of 
NF-kB and activatesvitamin D pathway: (i) the activation of NF-kB results 
in production and secretion of many proinflammatory mediators including 
cytokines TNF-a,IL-1, IL-12, IL-18 and chemokines, which attract 
neutrophils, natural killer (NK) cells, T cells, and more DC and macrophages 
to the infection site,
116,131
 and nitricoxide. It is of interest to note that 
M.tuberculosis secreted protein ESAT-6 could inhibit activation of NF-kB 
through preventing interaction between MyD88 and downstream kinase 
IRAK4;
180
 (ii) TLR activation also up regulates expression of the vitamin D 
receptor (VDR) and the vitamin D-1-hydroxylase genes, which converts pro-
vitamin D into the active form 1,25(OH)2D3 and leads to induction of the 
antimicrobial peptides cathelicidin and β-defensin to kill intracellular 
mycobacteria.
40,146
 NADPH oxidase2, which mediates phagocytic killing of 
ingested pathogens like M. tuberculosis via reactive oxygen species, interacts 
with TLR-2 and affects VDR mediated antimicrobial peptide production. 
Knockdown of NADPH oxidase 2 inhibited 1,25D(3)-mediated 
antimicrobial activity against M. tuberculosis through the modulation of 
cathelicidin expression in human macrophages.
269
 The importance of the host 
VDR and TLR in controlling TB is shown in polymorphisms in VDR and 
TLR-2 that are associated with increased susceptibility to TB 
infection.
18,236
In contrast, DC-specific intercellular-adhesion molecule-3-
grabbing non-integrin signal pathway activation leads to production of IL-10 
and transforming growth factor-β (TGF-β), which suppress the immune 
response.
116
 Macrophages are heterogeneous and have different roles during 
TB infection, that is,IL-23-producing type 1 macrophages that promote Th1 
immunity to mycobacteria, and IL-10-producing type 2 macrophages that 
suppress immunity to mycobacteria.
250
 The type 2 macrophages have been 
shown to induce CD4+ T cells to adopt a Treg CD25+FoxP3+mTGFβ-1+ 
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 Interferon-γ, secreted from activated T cells and 
NK cells have the capability to activate macrophages and promote bacterial 
killing by permitting phagosomal maturation and production of antimicrobial 
reactive nitrogen intermediates and reactive oxygen intermediates.
109
 Recent 
research also found that IFN-γ and TLR signalling pathways induce 
autophagy in macrophages,
91
 which enhances the delivery of ubiquitin 
conjugates to the lysosome and increases the bactericidal capacity of the 
lysosomal soluble fraction.
5
 Th1cytokine IFN-γ facilitates phagosome 
lysosome fusion (autophagy) through cell signalling pathway IRGm1(LRG-
47) and PI3K, whereas Th2 cytokines IL-4 and IL-13 abrogate autophagy 
and autophagy-mediated killing of M. tuberculosis through Akt signalling 
pathway.
57
 Besides IFN-γ, TNF-α also plays an important role in killing 
intracellular M. tuberculosis through reactive nitrogen intermediates together 
with IFN-γ and is involved in granuloma formation.81 TNF is needed for 
controlling LTBI as anti-TNF antibody infliximab increases the risk of 
activating latent TB47 through direct neutralization of TNF and also 
depletion of granulysin-expressing CD45RA+ subset of effector memory 
CD8+ T cells that contributes to the killing of intracellular M. tuberculosis.
29 
The CD1d-restricted NKT cells have recently been shown to mediate 
protection against M. tuberculosis in the mouse model.
195
 NK cells also 
contribute to protective immunity through killing CD4+CD25+FoxP3+Treg 
cells.
116
 In addition, invariant NKT have recently been found to inhibit 
development of Th17 cells,
137
 which may impact the pathology mediated by 
M. tuberculosis infection. The role of neutrophils in host defence against M. 
tuberculosis is conflicting. Polymorphonuclear neutrophils (PMN) are the 
first cells recruited to sites of microbial entry and express a range of 
receptors and avast arsenal of antimicrobial effector molecules as in 
macrophages.
116
 Most experiments on human PMN suggest that PMN could 
be activated in response to M. tuberculosis, and have the ability to restrict 
mycobacterial growth in vitro. For example, PMN produce human neutrophil 
peptides 1–3 and cathelicidin LL-37 and lipocalin 2, which have the ability 
to kill or restrict M.tuberculosis growth. Furthermore, PMN could activate 
macrophages through releasing granule proteins and heat shock protein 72 
from apoptotic neutrophils. However, on the other hand, PMN accumulated 
in M. tuberculosis-infected sites seem to have no obvious effect on 
mycobacterial growth and play a pathological rather than protective role in 
active disease. The results from different animal models are also conflicting. 
Some studies suggest neutrophils have a protective role during early stage of 
infection, while others suggest PMN do not play a role in control of TB. 
Mast cells seem to play a role in controlling M. tuberculosis infection as 
activation of mast cells via TLR-2 could compensate the defect in controlling 
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V-γ-9V-δ-2-encoded T cells are the main γ-δT cells in humans, which 
recognize non-peptidic phosphoantigens without known requirement for 
MHC molecules. Mature V-γ-9V-δ-2 T cells are rapidly recruited to the M. 
tuberculosis infection site, displaying a potent NK-like cytotoxic activity, 
expressing chemokine receptors, secreting a plethora of cytokines including 
IFN-γ and TNF-α, and killing M. tuberculosis-infected cells.33 Likeγ-δ T 
cells, activated CD1 molecules-restricted T cells that present mycobacterial 
glycolipid antigens produce IFN-γ and express cytolytic activity.109 These 
antigen-specific γ-δ T cells and CD1-restricted T cells have adaptive immune 
responses, and can have immune memory and mount rapid, strong recall 
expansion after M. tuberculosis reinfection.
140
 Furthermore, parts of γ-δT 
cells produce IL-17 and express TLR-1 and TLR-2, as well as dectin-1, and 
could directly interact with certain pathogens to orchestrate an inflammatory 
response after bacterial invasion.
139 
Collectively, these data indicate that several pathways and cell types 
interact to mediate innate immunity against M. tuberculosis, and provide 
likely mechanisms for the observation that many individualsfail to display 
any immunodiagnostic evidence of TB infection despite significant and 






Figure 3: Innate immunty to tuberculosis infection. M. tuberculosis is phagocytosed 
by macrophages and dendritic cells through membrane-bound receptors such as CR3, 
scavenger receptor, MMR, TLR, NOD2 and DC-SIGN. These lead to activation of 
macrophage signalling pathways (NF-kB), causing secretion of pro-inflammatory cytokines, 
chemokines, and antimicrobial molecules, and activation of VDR, which induces the 
expression of the antimicrobial peptides cathelicidin and β-defensin. In addition, induction of 
autophagy mediates antimicrobial activity. PMN cells recognize and engulf M. tuberculosis 
and secrete antimicrobial peptides to kill bacteria. NK cells, γδT cells and CD1-restricted T 
cells are also be activated by specific ligands and cytokines, release cytotoxic factors and 
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secrete IFN-γ, which activates macrophages. CR3, complement receptor 3; DC-SIGN, 
dendritic cell-specific intercellular-adhesion molecule-3-grabbing non-integrin; INF, 
interferon; MMR, macrophage mannose receptor; NK, natural killer; PMN, 
polymorphonuclear neutrophils; TLR, toll-like receptors; TNF, tumour necrosis factor; VDR, 





Figure 4: Adaptive immunity to tuberculosis infection. The infected macrophages 
and dendritic cells secrete cytokines that include IL-12, IL-23, IL-7, IL-15 and TNF-α, 
and present antigens to several T-cell populations including CD4+ T cells (MHC class II), 
CD8+ T cells (MHC class I), CD1-restricted T cells (glycolipid antigens) and γδ T cells 
(phospholigands). These T cells produce the effector cytokine IFN-γ, which activates 
macrophages in conjunction with TNF-α to effect killing of intracellular mycobacteria 
through reactive oxygen and nitrogen intermediates. In addition, CD8+ cytotoxic T cells 
can kill intracellular mycobacteria through granulysin and perforin-mediated pathways. 
However, CD4+ Th2 cells produce immunosuppressive cytokines such as IL-4, and 
CD4+CD25+FoxP3+ regulatory T (Treg) cells produce IL-10 and TGF-β that may 
suppress mycobactericidal effector mechanisms.
190
 A new subset of T helper cells called 
Th17 cells that are produced in the presence of IL-23, and are characterized by production 
of IL-17, is important modulator of inflammation and recall memory responses. Th17 
cells can recruit neutrophils and monocytes, and IFN-γ-producing CD4+ T cells, and 
stimulate chemokine expression. However, IFN-γ in turn can suppress the IL-17 
producing Th17 cells. Thus, there appears to be a more complex cross-regulation of Th1, 
Th2, Th17 and Treg cell responses, than previously recognized and the precise role of 
individual responses in protective immunity remain controversial. GM-CSF, granulocyte-
macrophage colony-stimulating factor; IFN, interferon; TGF, transforming growth factor; 
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Adaptive immunity to Mycobacterium tuberculosis 
Mycobacteria-infected macrophages and dendritic cells (DC) of the 
innate immunity present antigens to T cells and B cells that belong to 
adaptive immunity. CytokineIL-12p40 plays a fundamental role in the 
pathogen induced activation of pulmonary DC.
112
 Macrophage apoptosis that 
releases apoptotic vesicles to carry mycobacterial antigens to uninfected DC 
can lead tomore effective antigen presentation. Inhibition of macrophage 
apoptosis could reduce transfer of antigens to bystander cells and affect 
activation of CD8 T cells.
199
 
MHC class CD1-restricted CD4 T cells and MHC class CD1-restricted 
CD8 T cells that recognize peptide antigens and the γ-δ T lymphocytes as well 
as the CD1-restricted specific T lymphocytes produce IFN-γ and constitute the 
protective immunity (Figure 4). The CD4+ Th1 cells mount a much stronger 
IFN-γ response than CD8+ T cells after mycobacterial infection164 and are 
thought to play a prominent role in protection.
108
 The lack of CD4 T cells may 
result in delayed distribution of activated CD8 T cells from draining lymph 
nodes to distant organs and consequently cause a delayed acquisition of 
immune protection.
255
 The CD8 cytolytic T lymphocytes (CTL) secrete 
granulysin, granzymes and perforins to kill mycobacteria-infected cells and 
are capable of immune protection against secondary mycobacterial challenge 
in the absence of CD4+ T cells.
164
 
The CD4 T helper cells can be differentiated into Th1, Th2, Th17 and 
Treg cells. The Th1 cells produce cytokines, notably IFN-γ, TNF-α, IL-2, 
lymphotoxin and granulocyte-macrophage colony-stimulating factor (GM-
CSF), which prompt stimulation of Th1 cells, CTL, and maturation and 
activation of macrophages as well as granulocytes. The Th2 cells produce B 
cell-stimulation factors such as IL-4, IL-5,IL-10 and IL-13, which promote 
antibody production but suppress the Th1 type immune response. The Th17 
cells, a distinct subset of helper T cells, produce unique cytokines of IL-17, IL-
17F, IL-21 and IL-22, which stimulate defensin production and recruit 
neutrophils and monocytes to the site of inflammation, and are involved in the 
early phase of host defence. The Th1, Th2 and Th17 subsets may be modulated 
by Treg cells, of which there are several types and the list is growing. The 
CD4+CD25+FoxP3+ natural Treg cells are characterized by TGF-β and IL-10 
production,
60,110
 while the Treg cells also co-produce IFN-γ.241 In addition to 
CD4+ Treg cell subsets, CD8+ Treg cells are also described, which could 
inhibit T-cell proliferation and cytokine production.
102
 The FoxP3-expressing 
Treg cells are expanded during TB infection,
203
 and inhibit human memory γ-δ 
T cells to produce IFN-γ in response to M. tuberculosis antigens.127 However, 
phosphoantigen-activated Vγ2Vδ2T cells could antagonize IL-2-induced 
CD4+CD25+Foxp3+ Treg cells in mycobacterial infection.
86
 
CD4+CD25+FoxP3+  Treg cells also produce TGF-β to down regulate CD4+ 
T-cellresponse,
121
 and suppress the effector-immune response and induce 
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bacillary dissemination and disease manifestation.
187,206
 High per cent of Treg 
cells characterized as CD4(+)CD25(high)CD39(+) was also identified in active 
TB patients.
39
 Attenuation of Treg cells has a positive impact on the protective 
capacity of vaccine against M. tuberculosis infection.
14,101
 Nevertheless, given 
the extensive immunopathology and lung damage that characterize human TB, 
the precise role of Treg cell (deleterious, beneficial or bystander) in the 
immunopathogenesis of TB remains unclear. 
Different cytokines can decide the differentiation of T-cell sets (Figure 
4). IL-12, IL-18 and IFN-γ promote Th1 cell development, while IL-4, IL-5 
and IL-13 induce Th2 cell development. IL-23, Il-6, IL-21 and low 
concentration of TGF-β could induce Th17 differentiation, while IL-2 and 
high concentration of TGF-β could induce Treg differentiation.110,60 IL-6 
inhibits the generation of Treg cells induced by TGF-β, but together with 
TGF-β induces the differentiation of Th17 cells.20 
 
Traditionally, B cells are not generally thought to play a 
significant role in protection against TB. However, recently it has been 
demonstrated that B cells
2
 are required for optimal protection in M. 
tuberculosis-infected mice through interactions with the cellular immune 
response and activation of complement.
132
 M. bovis Bacille Calmette Guérin 
(BCG) directly activates the classical, lectin and alternative pathways, 
resulting in fixation of C3b onto macromolecules of the mycobacterial 
surface,
32
 which will contribute to mycobacterial killing. 
Memory T (TM) cells form after M. tuberculosis exposure or 
















TM cells proliferate promptly after encounter with antigens, and produce 
multiple cytokines such as IFN-γ, IL-2, TNF-α, lymphotoxin and/or GM-
CSF.
110
 Nevertheless, the identification of specific biomarker signature of 
protective immunity remains elusive. Multifunctional CD4+ T-cell 
responses, like those raised to the TB subunit vaccine, Ag85B-ESAT-
6/CAF01-induced, may be a better marker of protective immunity.
57 
 
2.2.3. Genomic organization and genes of M. tuberculosis 
TB research made huge progress with the availability of the genome 
sequence of the strain M. tuberculosis H37Rv.
42
 Expectations were generated 
on the elucidation of some unique characteristics of the biology of the 
tubercle bacillus, such as its characteristic slow growth, the nature of its 
complex cell wall, certain genes related to its virulence and persistence, and 
the apparent stability of its genome. This first available genome sequence of 
a pathogenic M. tuberculosis strain helped to answer some of these questions 




 was revealed to possess a sequence of 
4,411,529 bp (Figure 5), the second largest microbial genome sequenced at 
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that time. The characteristically high guanine plus cytosine (G+C content; 
65.5 %) was found to be uniform along most of the genome, confirming the 
hypothesis that horizontal gene transfer events are virtually absent in modern 
M. tuberculosis .
220.
 Only a few regions showed a skew in this G+C content. 
A conspicuous group of genes with a very high G+C content (> 80 %) 
appear to be unique in mycobacteria and belong to the family of PE or PPE 
proteins. In turn, the few genes with particularly low (< 50 %) G+C content 
are those coding for transmembrane proteins or polyketide synthases. This 
deviation to low G+C content is believed tobe a consequence of the required 
hydrophobic amino acids, essential in any transmembrane domain, that are 
coded by low G+C content codons.
177
 
Fifty genes were found to code for functional RNAs. As previously 
described,
111
 there was only one ribosomal RNA operon (rrn). This operon 
was found to be located at 1.5 Mbp from the origin of replication (oriC 
locus). Most eubacteria have more than one rrn operon located much closer 
to the oriC locus to exploit the gene-dosage effect during replication.
43
 The 
possession of a single rrn operon in a position relatively distant from oriC 
has been postulated to be a factor contributing to the slow growth phenotype 





Figure 5: Circular map of the chromosome of M. tuberculosis H37Rv. The outer 
circle shows the scale in Mb, with 0 representing the origin of replication. The first ring 
from the exterior denotes the positions of stable RNA genes (tRNAs are blue, others are 
pink) and the direct repeat region (pink cube); the second ring inwards shows the coding 
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sequence by strand (clockwise, dark green; anticlockwise, light green); the third ring 
depicts repetitive DNA (insertion sequences, orange; 13E12 REP family, dark pink; 
prophage, blue); the fourth ring shows the positions of the  PPE family members (green); 
the fifth ring shows the PE family members (purple, excluding PGRS); and the sixth ring 
shows the positions of the PGRS sequences (dark red). The histogram (centre) represents 
G + C content, with < 65% G + C in yellow, and > 65% G + C in red. The figure was 
generated with software from DNASTAR. (From Cole et al., 1998) 
 
One of the most thoroughly studied characteristic of M. tuberculosis is 
the presence and distribution of insertion sequences (IS). Of particular 
interest is IS6110, a sequenceof the IS3 family that has been widely used for 
strain typing and molecular epidemiology due to its variation in insertion site 
and copy number.
243
 Sixteen copies of IS6110 were identified in the genome 
of M. tuberculosis H37Rv; some IS6110 insertion sites were clustered in 
sites named insertional hot-spots. The same strain was found to harbor six 
copies of the more stable IS1081, an insertion sequence that yields almost 
identical profiles in most strains when analyzed by Restriction Fragment 
Length Polymorphism (RFLP).
106,215
 Another 32 different insertion 
sequences were found, of which seven belonged to the 13E12 family of 
repetitive sequences; the other insertion sequences had not been described in 
other organisms.
45
 Virtually all the ISs found in M. tuberculosis so far belong 
to previously described IS families.
49
 The only exception is IS1556, which 
does not fit into any known IS family.
44
 
Two prophages were detected in the genome sequence; both are 
similar in length and also similarly organized. One is the prophage PhiRv1, 
which in the M. tuberculosis H37Rv genome interrupts a repetitive sequence 
of the family 13E12. This prophage is deleted or rearranged in other M. 
tuberculosis strains.
80
 The genome of M. tuberculosis possesses seven 
potential att sites for PhiRv1 insertion, which explains the variability of its 
position between strains.
44
 The second prophage, PhiRv2 has proven to be 
much more stable, with less variability among strains.
44
 
Regarding protein coding genes, it was determined that M. 
tuberculosis H37Rv codes for 3,924 ORFs accounting for 91 % of the coding 
capacity of the genome.
42
 The alternative initiation codon GTG is used in 35 
% of cases comparedto 14 % or 9 % in Bacillus subtilis or Escherichia coli 




A bias in the overall orientation of genes with respect to the direction 
of replication was also found. On average, bacteria such as B. subtilis have 
75 % of their genes inthe same orientation as that of the replication fork, 
while M. tuberculosis only has 59 %. This finding has led to the hypothesis 
that such a bias could also be part of the slow growing phenotype of the 
tubercle bacillus.
44
 This conjecture, however, does not take into account the 
fact that E. coli, a bacterium that grows much faster than M. tuberculosis, has 
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only 55% of its genes in the same directionas the replication origin.
126 
From the predicted ORFs, all proteins have been classified in 11 broad 
functional groups, more precisely classified into COG functional categories 
(http://www.ncbi.nlm.nih.gov/sutils/coxik.cgi?gi=135) according to the 
National Center for Biotechnology Information (NCBI) of the United States 
(US). The analysis of the codon usage showed a preference for G+C-rich 
codons. It was also found that the number of genes that arose by duplication 
is similar to the number seen in E. coli or B. subtilis, but the degree of 
conservation of duplicated genes is higher in M. tuberculosis. The lack of 
divergence of duplicated genes is consistent with the hypothesis of a recent 
evolutionary descent or a recent bottleneck in mycobacterial evolution.
23
 
From the genome sequence it is clear that M. tuberculosis has the 
potential to switch from one metabolic route to another including aerobic 
(e.g. oxidative phosphorylation) and anaerobic respiration (e.g. nitrate 
reduction). This flexibility is useful for survival in the changing 
environments within the human host that range from high oxygen tension in 
the lung alveolus to microaerophilic/anaerobic conditions within the 
tuberculous granuloma. Another characteristic of the M. tuberculosis 
genome is the presence of genes for synthesis and degradation of almost all 
kinds of lipids from simple fatty acids to complex molecules such as mycolic 
acids. In total, there are genes encoding for 250 distinct enzymes involved in 
fatty acid metabolism, compared to only 50 in the genome of E. coli.
44
 
Concerning transcriptional regulation, M. tuberculosis codifies for 13 
putative sigma factors and more than 100 regulatory proteins. Among the 
most interesting protein gene families found in M. tuberculosis are the PE and 
PPE multigene families, which account for almost 10% of the genome 
capacity. The names PE and PPE derive from the motifs of Pro-Glu (PE) and 
Pro-Pro-Glu (PPE) found near the protein N-terminus in most cases. These 
proteins are believed to play an important role in survival and multiplication 
of mycobacteria indifferent environments.
136
 There are about 100 members of 
the PE family, which is further divided into three sub-families, the most 
important of which is the polymorphic GC-rich sequences (PGRS) class that 
contains 61 members. Proteins in this class contain multiple tandem 
repetitions of the motif Gly-Gly-Ala, hence, their glycine concentration is 
superior to 50 %. The PE_PGRS proteins resemble the Epstein-Barr virus 
nuclear antigens (EBNA), which are known to inhibit antigen presentation 
through the histocompatibility complex (MHC) class I.
44
 
Interestingly, the analysis of the desoxyribonucleic acid (DNA) 
metabolic system of M. tuberculosis indicates a very efficient DNA repair 
system, in other words, replication machinery of exceptionally high fidelity. 
The genome of M. tuberculosis lacks the MutS-based mismatch repair system. 
However, this absence is overcome by the presence of nearly 45 genes related 
to DNA repair mechanisms,
149
 including three copies of the mutT gene. This 
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gene encodes the enzyme in charge of removing oxidized guanines whose 
incorporation during replication causes base-pair mismatching.
44,149
 
As more information was generated, databases grew bigger, more 
experimental information became available, and better and more accurate 
algorithms for gene identification and prediction were released. The initial 
genome annotation in M. tuberculosis H37Rv strain soon became out of date. 
For this reason, a re-annotation of that genome sequence was published in 
2002. This re-annotation incorporated 82 additional genes. The gene 
nomenclature was not altered; the new genes have the name of the preceding 
gene followed by A, B or D, for example, two new ORFs were described 
between Rv3724 and Rv3725, hence, they were named Rv3724A and 
Rv3724B. The letter C was not included since it usually stands for 
“complementary”, which means that the gene is located in the 
complementary strand. As expected, the classes that exhibited the greatest 
numbers of changes were the unknown category and the conserved 
hypothetical category. The reannotation of the genome sequence allowed the 
identification of four sequencing errors making the current sequence size 
change from 4,411,529 to 4,411,532 bp.
31
 
In Table 3, the information obtained from a single sequenced 
genomeis enormous. The advances made on the analysis of such information 
have accelerated TB research.
 




















0 Virulence, detoxification,  
adaptation 
91 99 212 
1 Lipid metabolism 255 233 237 
2 Information pathways 207 229 232 
3 Cell wall and cell processes 516 708 751 
4 Stable RNAs 50 50 50 
5 Insertion sequences and  
phages 
137 149 147 
6 PE and PPE proteins 167 170 168 
7 Intermediary metabolism and  
respiration 
877 294 898 
8 Protein of Unknown function 606 272 15 
9 Regulatory proteins 188 189 194 
10 Conserved hypotheticals 910 1051 895 
16 Conserved hypotheticals with  
an orthologue in M. bovis 
NA NA 262 
a. The functional groups number were taken from the Tuberculist database, publically 
available at http://genolist.pasteur.fr/TubercuList/. 
b. Data taken from Fleischman 2002
80
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2.2.4. Molecular mechanism ofdrug resistance to rifampicin, izoniazid, 
ethambutol and streptomycin of M.tuberculosis 
Tuberculosis is a major threat to global public health that demands 
new approaches to disease diagnosis and treatment. Understanding at the 
genomes of different strains, we can know the mechanism of drug resistance 
of M. tuberculosis that may help develop better treatments. 
M. tuberculosis becomes resistant to antibiotics by chromosomal 
mutation, which confers resistance to a TB drug. The accumulation of these 
mutations leads to multi-drug resistance. Unlike horizontal transfers, which 
involve the acquisition of DNA fragments with different origins, mutations 
that confer resistance to TB drugs affect isolated portions of bacterial 
chromosome. Thus by detecting them, the strain's resistance can be 
predicted. This is particularly easy in the case of antibiotics to which 
resistance is caused by the alteration of an essential gene matching the 
antibiotic target. Very few mutations could cause a loss of interaction 
between the target and the antibiotic without affecting the gene's function. 
Thus, only a few permissive mutations of the antibiotic's target will be 
observed. In the case of resistances to rifampicin (RIF) or fluoroquinolones 
(FQ), permissive mutations primarily affect a small fragment of rpoB 
(coding for RNA polymerase) and gyrA (coding for DNA gyrase) genes 
respectively. This is also the case for aminoglycoside resistance, which is 
caused by mutations in the translation machinery genes (rrs and rpsL) and 
can only becaused by permissive mutations. These mutations, which affect 
vital genes, lead to a loss of affinity for the antibiotic without destroying the 
gene‟s function. However, when antibiotic resistance is caused by the loss of 
function of a non-essential gene, a broad spectrum of mutations will be 
observed, which makes detecting them difficult. This will involve any 
mutation that inactivates the gene. In order to detect these mutations, the 
complete sequence of the mutated genes will need to be known. In addition, 
mutation will not necessarily mean the loss of gene function, and therefore 
antibiotic resistance. This is the case for example, of the pncA gene, which is 
inactivated by mutation in the event of resistance to pyrazinamide (PZA), 
and the genes involved in isoniazid (INH) resistance. The pncA gene is a 
small gene that can be easily sequenced to find mutations. However, a large 
number of mutations have been observed in strains susceptible to PZA. 
These mutations do not affect gene function. High-level resistance to INH is 
often due (approximately 75% of cases) to the same point mutation in katG. 
Thus isolating it for a large number of strains is easy and can be done to 
identify the resistance. Resistance can only be linked to a mutation on one 
gene or be the result of single or multiple complex mutations on different 
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In use since 1966, Rifampicin (RIF) is an important component in 
treating tuberculosis. It is a broad spectrum rifamycin derivative that 
interferes with the synthesis of mRNA synthesis by binding to the ß subunit 
of RNA polymerase (RpoB) in bacterial cells. The RIF binding site is a 
pocket in the upper wall of the main channel for double-stranded DNA entry 
just upstream of the polymerase catalytic center. The various RIF-resistant 
mutations are clustered around this pocket.
273
 Thus, RIF resistance is 
associated with a hotspot (codon 507 to 533) core region called RRDR, for 
“rifampicine resistance determining region” (81 bp) of the rpoB gene.231,232 




Resistance occurs at a frequency of 1 out of 107 to 108 bacterial cells. 
Most RIF-resistant strains show one mutation in the gene. Two to four 
mutations are rarely reported.
134,205
 The most prevalent mutations (81%) 
affect codons 531 and 526 and usually lead to a high level of phenotypical 
resistance (MIC > 64 μg/ml) as well as cross resistance to other rifamycins. 
Mutations 511, 516, 518 and 522 result in a low-level resistance to RIF and 
rifapentine; and some susceptibility to rifabutin.
272
 At the same time, 
mutations in this hotspot region seem to confer low phenotypical resistance 
(deletion of codon 508-509, mutation at 515)
229
 or variable resistance 
(L533P),
114
 which could lead to an overly hasty interpretation of resistance. 
The latest observations of Asian strains suggest a geographic variability that 
can influence the accuracy of genotypic tests.
192
 
Silent mutations (Leu511 and Leu521) have been reported in resistant 
strains. Interestingly, the L511L mutation is always associated with other 
mutations that confer resistance.
209
 In rare cases, double mutations appear to 
have an additive effect on the degree of resistance. The role of mutations, 
combined with those known to confer resistance, is uncertain, as in the case 
of S509R described with H526R.
205
 
Finally, less than 5% of resistant strains do not show a mutation in the 
rpoB resistance region.
134,192
 Rare loci found outside the hotspot region of 
rpoB are associated with resistance without associated mutation known for 
conferring resistance. The CTG Leu 533 Pro CCG mutation has been shown 
on two strains of low-level resistance (MIC 12.5 μg/ml) and on a strain that 
is susceptible according to phenotypic tests, yet clinically resistant.
192
 Other 
studies describe some sensitive strains with mutations as Ser 450 Leu,
205
 Leu 
511 Arg or Ser 512 Thr,
150
 or Gln CAA 513 Gln CAG.
114
 Genotypic 
detections would therefore be more sensitive in certain circumstances. 
Resistance to rifampicin, which usually develops with resistance to INH, 
thus defines the strain as multi-resistant (MDR). However, there are rare 
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The first mutation detection studies were based on PCR sequencing or 
PCR-SSCP (single strand conformational polymorphism analysis (SSCP). 
Now,  resistance is frequently screened by one of the methods on the market 
(INNOLIPARif.TB or GenoType MTBDRplus, HAIN).
96
 In these tests, a 
decontaminated sample is amplified with biotin labeled amplicons. This 
amplification product is hybridized on a test stripcontaining oligonucleotides. 
The reaction identifies the signals as parallel marks on the test strip. Thus the 
presence or absence of a mutation is easily detected in a few hours. To identify 
rifampicin resistance, the Hain MTBDRplus test strip has 8 probes that 
recognize wild mutations and four that correspond to the most frequently 
observed mutations (S531L, H526Y, H526D, and D516V of rpoB, mutations 
observed in 75% of RIF resistances). The test is rapid and easy, and can be 
applied to samples that are positive upon direct exam or to advanced cultures. 









In summary, the RIF binding site to polymerase is a pocket around which 
the mutations observed on resistant strains are clustered. These mutations are 
found in nearly all of the strains (>95%). Thus, analyzing this core sequence 
makes it easy to detect RIF resistant strains and predict their resistance level. It 
also provides strong concordance among results from different geographic 
regions. Furthermore, the frequency of mutations among resistant strains is very 
high: 100% (n=28) in Japan,
205
 100% (n=93) or 98%(n=44) in two Indian 
studies.
209,134
 Only silent mutations are observed. Diagnostic difficulty could be 
caused by rare inconsistencies where mutated strains are phenotypically 
susceptible. One of them may even be clinically resistant, which could suggest 
greater genotypic test sensibility.
182
 
Commercial amplification/reverse hybridization kits provide rapid, 
effective detection of the mutations most commonly responsible for 
rifampicin resistance. 
Based upon rpoB core region analysis, the Cepheid gene Xpert 
System‟shands-free sputum processing and real-time PCR system (with 
rapid ondemand,near-patient technology), simultaneously detects M. 
tuberculosis and RIF resistance within 2 hours from smear-negative and 
smear-positive clinical sputum samples. The self-contained cartridge fluidics 
of the XpertMTB/RIF assay make it possible to design a hemi-nested PCR 
assay with asensitivity that approaches culture-based diagnostics. An internal 
control target detects false-negative results. The GenoType MTBDRplus test 
(Hain) is able to identify resistance to RIF by detection of mutation in the 
core region of the rpoB gene. Mutations are identified by an amplification 
method and reverse hybridization on test strips.
182
 
The MTBDRplus strip contains 17 probes, including 5 amplification 
and hybridization controls to verify the test procedures. For the detection of 
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RIF resistance, five rpoB wild-type probes (probes WT1 to WT5) encompass 
the region of the rpoB gene encoding amino acids 509 to 534. Four probes( 
probes rpoB MUT D516V, rpoB MUT H526Y, rpoB MUT H526D, and 
rpoB MUTS531L) specifically target the most common mutations. The 
Hillemann evaluation
96
 detected an association with rpoB mutations in 96.8 
to 98.7% of RIF resistant strains. 
 
Isoniazid Resistance 
Since 1952, Isoniazid (INH) has been one of the most effective and 
specific agents for treating M. tuberculosis infections. This is an essential TB 
drug that, along with RIF and PZA, forms the base for treating susceptible 
tuberculosis and is also widely prescribed for treating latent infections. INH 
is very active (MIC 0.02 to 0.2 μg/ml) on M. tuberculosis. It is a simple 
structure made up of a pyridine ring and a hydrazide group, two essential 
components to its powerful activity against increasing M. tuberculosis.
272
 It 
has one of the most complex modes of action among all antibiotics. INH is a 
prodrug that requires activation of the catalase-peroxidase enzyme (KatG) 
coded by the katG gene.
274
 Once activated, INH seems to destroy the 
synthesis of mycolic acids of the cell wall by inhibiting NADH-dependent 
enoyl-ACP reductase coded by the inhA gene. It encourages the bacterial cell 
to produce toxic free radicals. Resistant strains appeared shortly after the use 
of INH in clinical treatment, many of whom had lost their catalase activity. 
The increasing observation of INH-resistant strains, up to 20-30% of strains 
in some regions,
41
 which is the first step towards multiresistance, have cast 
doubts on its use as a first-line treatment of tuberculosis. 
Resistance develops with a high mutation frequency (1 for 106), 
higher than that of rifampicin (1 for 107 to 108). There are many molecular 
mechanisms causing INH resistance, but only some of them have been 
characterized. A recent review explains them by their molecular analysis.
251
 
Mutations in the katG gene, which hinder activation of the INH 
prodrug, are among the most frequent in INH-resistant strains: 20 to 95% 
INH-resistant strains have at least one mutation in the katG gene; its position 
varies according to their geographical origin.
92,102,188,192,272,274
 The S315T 
mutation is the most frequent (75 to 90%) even up to 93.6%.
153
 It lowers 
catalase peroxidase activity by 50% and leads to a relatively high level of 
resistance (MIC from 5 to 10 μg/ml), without cross-resistance to 
ethionamide. It alters INH activity by preventing bond formation between 
INH and KatG. Strains with acomplete deletion of the katG gene may have 
an MIC equal to at least 50μg/ml.182 
R463L substitution, found in M. bovis, M. africanum and M. canettii, 
is not considered to be a source of resistance in M. tuberculosis, where it is 
found in15 to 30% of cases, regardless of whether the strain is susceptible or 
resistant.
113
 The Siddiqi study in 2002
209
 analyzed 24 INH-resistant strains 
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and reported other insertions, deletions, and substitutions on the katG gene: 
an AC deletion at position 30 on six strains, resulting in the synthesis of a 
small polypeptide; a G deletion at position 109 on two strains, resulting in a 
truncated polypeptide; an A inserted at 98 and a C at 185 on four and three 
strains respectively, causing premature 20 polypeptide chain terminations. 
Only a few strains had new substitutions: Ala61Thr, Thr12Pro, Thr11Ala, 
Asp73Asn and Asn35Asp. One strain had a partial gene deletion. All of the 
isolates in this study had the Arg463Leu mutation, which was not related to 
resistance. Loss of catalase activity is not the only cause of resistance. 
Resistance can also develop through alterations or an overexpression of the 
InhA
12
 target, which codes for NADH-dependent enoyl-ACP reductase. 0 to 
5% of INH-resistant strains have a mutation in the structural gene while 8 to 
20% have a mutation in the InhA, MabA promoter.
13,159,188,274
 20 to 34% of 
INH-resistant strains have at least one mutation in MabA promoter, which is 
either alone or combined with a mutation in theInhA gene. Hazbon
92
 
identifies 51 mutations in inhA in 3/608(0.5%) of INH susceptible strains 
and 48/403 (12%) of INH resistant strains. All of the promoter mutations 
(except G17T) are observed in INH resistant strains, which are usually 
associated with the C-15-T mutation. All of the structural gene mutations 
(except I47T and I194T) were only detected on INH resistant strains. The 
inhA S94A mutations, which seem to alter the INH-NADH bond with InhA, 
are restricted to INH resistant strains.
125,251
 Most of the strains that have one 
mutation in inhA, with no mutation in katG, have a relatively low level of 
resistance > 0.2 μg/ml and < or equal to 1 μg/ml. In 1998, mutations of the 
kasA gene, which codes for ß-ketoacyl ACP synthetase, were reported in 
INH resistant strains, with genetic complementation showing no proof that 
mutations were involved in resistance.
144
 These mutations were found in 
INH resistant strains as well as INH susceptible strains. In Hazbon‟s study,92 
kasA mutations were identified at 66, 269 and 312 in 100/608 (16%) of INH 
resistant strains and 44/403 (11%) of susceptible strains. The kasA G312S 
mutation is unrelated to resistance in thestudy of 98 strains.
225
 These results 
prove that none of the mutant KasA alleles are on INH resistant strains alone. 
In three M. tuberculosis strains, overexpression of KasA did not increase 
resistance to INH or EMB, in contrast to InhA.
122
 The role of KasA in 
resistance is still undetermined. 
Mutations were found in the ahpC gene, which codes for an 
alkylhydroperoxide reductase, for 10% to 13% of resistant strains 
92,192
 and 
also in susceptible strains.
92
 Those that are located at position -46 (the most 
frequent), -9 (G at A) or D73H are not related to resistance. The only 
mutation found exclusively on INH-resistant strains is T51. These mutations 
are always related to mutations in katG, but rarely to those of codon 315.
192
 
Mutations in the ndh gene, which codes for NADH dehydrogenase, were 
found in a small number of clinical strains (3% of INH resistant and INH 
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susceptible strains for one study and 9% of INH resistant strains in another 
study).
92,123
 These mutations confer resistance to INH and to ethionamide. 
The most frequent is V18A, which was observed independently from 
susceptibility. Only one mutation in ndh, R268H, is found exclusively on 
clinical strains of INH-resistant M. tuberculosis.
92,123,251
 Other genes could be 
involved in resistance. 
The NAT gene, coded for an arylamine N-acetyl transferase. The NAT 
protein of M. tuberculosis acetylates the INH nitrogen group, thus preventing 
the KatG gene from activating it. NAT mutations observed in clinical strains 
of INH resistant were always associated with mutations in katG, but also 
found in INH susceptible strains.
188,251
 
Studies on clinical INH resistant strains identified mutations on other 
genes such as furA, Rv 0340-0343, Rv1772, fadE24, efpA,
251
and so on. These 
mutations were related for the most part to mutations in katG and/or in the 




Several studies have focused on the interactions between genes. The 
recognition of simultaneous mutations in two genes, KatG and InhA, is 
associated with resistance in 75% to 85% of cases.
90,102
 Finally, many of the 
strains (n=1,011) analyzed in Hazbon‟s study92 were able to demonstrate a 
strong individual association between mutations of the katG, inhA, and ahpC 
genes and resistance to INH (P = 0.0001), while kasA mutations were 
associated with susceptibility. Remarkably, there were more mutations 
(particularly katG315) among MDR strains than among strains that were 
only resistant to INH. In this last case, mutations of the inhA gene were more 
frequent. Moreover, significant associations were described between 
mutations of the katG, inhA, and ahpC genes and RIF resistance, while 




The phenotype for INH tolerance in M. tuberculosis strains is 
described as being genetically susceptible, but remaining active after INH 
treatment. The iniA gene of M. tuberculosis is associated with this 




In summary,there is high frequency of INH resistant mutations (10
-6
). 
INH resistant strains most often show at least one mutation in the katG gene. 
This gene is located in a hypervariable region of the genome, containing 
repeated elements, and which as a result could contribute to the high 
frequency of mutations of this gene in resistant strains. There could be a 
boost in KatG mutations at position 315 (the most frequent) because the 
mutations in this location seem to decrease INH activation without stopping 
catalaseperoxidase activity, which is a virulence factor in strains. M. 
tuberculosis can also offset mutations in the katG gene by overexpressing the 
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The description of inhAS94A mutations, which seem to alter the bond 
between the INH-NADH compound and InhA, corresponds to known 
interactions between NH and InhA. This suggests that inhA mutations play a 
role in resistance.
92
 The role of the KasA gene in INH resistance remains 
undetermined. The outcomes of the mutations observed in the ahpC 




Isoniazid resistance is thus complex. The genes involved are either 
non essential, or extragenic mutations can compensate for their absence. 
Multiresistance development could be influenced by the interactions between 
these genes. The complexity of detecting isoniazid resistance was 
highlighted in 2003 by the description of katG mutations, associated with 
resistance and identified on INH susceptible strains. In addition, 
approximately 9 to 25% of resistant strains contain no mutations in targets 
known to confer resistance.
90,115,181,188,231
 The decline in the effect of INH 
may be caused by the persistence of INH-tolerant bacilli.
253
 This could 
explain the high rate of clinically-observed resistance.
182
 
The recently marketed GenoType MTBDRplus test (Hain) is able to 
detect resistance to isoniazid by mutation in the katG and inhA genes. 
Mutations are identified by the amplification method and reverse 
hybridization on test strips. One probe covers the wild-type S315 region of 
katG, while two others (probes katG MUT T1 and MUT T2) are designed to 
assess the AGC-to-ACC (S315T) and the AGC-to-ACA (S315T) mutations. 
For the promoter region of the inhA gene, an inhA WT1 probe covers the 
wild-type region from -9 to -22 and a second inhA WT2 probe covers the 
positions from -1 to-12. Four mutations (-15C/T,-16A/G, -8T/C, and -8T/A) 
can be targeted with the inhA MUT1, MUT2, MUT3A, and MUT3B probes. 
The absence of hybridization with a wild-type probe indicates resistance. 
This test can identify mutations in a few hours. Mutations in katG resulted in 
a high level of isoniazid resistance, and mutations in inhA resulted in low 
levels of resistance. The Hillemann evaluation  detected an association with 
katG315 or InhA mutations is 92% of INH resistant strains.
96 
 
Ethambutol resistance    
Ethambutol (EMB) is very specific. It has been used since 1966 in 
combination with INH in treating tuberculosis. It is used as an accessory 
drug in short-course therapy, particularly when resistance to at least one TB 
drug reaches 4%.
192
 EMB inhibits the formation of mycobacterial 
membrane.
159
 Three homologues of arabinosyl transferases, EmbC, EmbA, 
and EmbB 
233
 have been proposed as the targets of EMB. These enzymes are 
involved in the synthesis of arabinogalactan, one of the basic components of 
a mycobacterial cell wall. 
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Resistance to EMB is frequent among MDR strains.
175
 Phenotypic 
resistance is difficult to standardize in part due to the instability of EMB in 
both solid and liquid culture mediums. The overexpression of genes, leading 
to low intracellular rates of EMB, or mutation of the codon at position 306 of 
the embB gene can cause higher resistance.
233
 Some reports have suggested 
that the EmbB306 mutation is not involved in EMB resistance but is instead 
associated with the development of other drug resistance including MDR-TB. 
A Russian study found mutations of embB306 in 48.3% of resistant strains, as 
well as in 31.2% of susceptible strains.
154
 Recently, Hazbon tested 1,020 
strains from different regions of the world and concluded that embB306 
mutations are associated with multi-resistance but do not directly cause 
resistance.
92
 Shortly after wards, Plinke et al. reported that embB306 
mutations were only detected on EMB resistant strains, suggesting that they 
predict resistance.
185
 Finally, Shen in Shanghai studied 10,659 strains and 
described embB306 mutations in EMB resistant and EMB susceptible 
strains.
207
 Using site-directed mutagenesis and allelic exchange in M. 
tuberculosis, Safi
196
 found that mutations leading to certain amino acid change 
are indeed causing EMB resistance while others have little effect on EMB 
resistance. 
Other mutations were observed: D354A and N296Y at codon 330 
(n=1)
205
 and 360 (n=2) of embB, which produced a high level of resistance,
222
 
or at codons 328, 406 and 497,
272
 and in embA and embC of some resistant 
strains.
222
 However, there are substitutions of codon 981 in phenotypically 
susceptible strains.
222
 Moreover, other mutations were observed in other genes 
such as embR, Rv0340, rmlD, and rmlA2, associated with resistance. Finally, 
for approximately 25% of low resistance strains (MIC <10 μg/ml), no mutation 
in the known resistance region was observed.
233
 This low level resistance could 
result from an overexpression of EmB or mutations outside of the sequenced 
region (approximately 80% of the3297 bp gene).
182
 
Multi-resistant strains have more embB306 mutants than non-MDR 
strains.
3,103,154,185
 The embB306 locus appears then as a marker candidate for 
detecting MDR and XDR M. tuberculosis strains.
182
 
A line probe assay is now proposed to detect ethambutol resistant strains.
97
 
The genotype MTBDRsl (Hain) test is based on amplification/reverse 
hybridization and provides detection of the embB mutations most commonly 
responsible for EMB resistance. Wild typeprobes have been designed that 
hybridize to the most important resistance region of the embB gene. When all 
wild type probes of a gene stain positive, there is no detectable mutation 
within the examined region. Hence, the strain tested is sensitive to EMB. 
When a mutation exists, the respective amplicon cannot bind to the 
corresponding wild type probe. The absence of a signal with at least one of the 
wild type probes indicates resistance to EMB. The mutation probes detect four 
306 embB mutations. The banding pattern obtained with the embB probes 
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Streptomycin (STR), an aminoglycoside antibiotic, was the first 
antibiotic used against tuberculosis in 1944 but its required parenteral 
administration,toxicity, and low effectiveness compared to other drugs has 
made it less prescribed as a first-line treatment. Its initial use in monotherapy 




Aminoglycoside antibiotics act by preventing protein synthesis of 
bacterial ribosome. They inhibit the initiation of mRNA translation. The site 
of action is the small 30S ribosome subunit, a highly conserved part of the 
translation apparatus including S23 ribosomal protein, coded by the rpsL 
gene, and ARNr16S coded by the rrs gene. Changes in the amino acid 
sequence of rpsL alter RpsL and ARNr16S interaction and lead to STR 
resistance. S12 ribosomal protein interacts with the 530 loop of ARNr16S, 
and maintains its super-structure. Thus, the ARNr16S loops that interact with 
the S12 protein are a mutation selective site for conferring resistance to STR. 
In bacteria, the presence of several rRNA operons and one copy of the rpsL 
gene prevent the isolation of STR resistant mutants whose resistance is 
conferred by amutation on the rrs gene. M. tuberculosis only has one rRNA 
operon (rrn),which explains the isolation of STR resistant whose resistance is 
conferred by a mutation of the rrs gene
182
. 
A 50% [42% to 59%] of STR resistance strains have at least one 
mutation in the rpsL gene, which codes for the S12 ribosomal protein 
associated with a high level of resistance (MIC > 1000 μg/ml) 159,160. 
Two rpsL mutations, Lys(AAG)Arg(AGG), at codons 43 and 88, 
contribute to these high levels of resistance in most cases.
79,145
 The rpsL 
mutants can host missense mutations at position 9 and 93 that have no 
obvious association to a role in STR resistance
221
 since they are described in 
association with mutations that are already known at codons 43 and 88. 
In certain strains of STR resistant M. tuberculosis, the rpsL gene is a 
wild type and resistance is attributed to mutations of the rrs gene coding for 
16S ribosomalRNA: 8 to 21% of STR resistant strains have at least one 
mutation in the rrs gene associated with an intermediary resistance level 
(MIC 64 to 512 μg/ml) 205,219. 
The first mutation described is A904G.
62
 Resistances are associated 
with single mutations, mainly in one of two conserved regions of ARNr16S 
(around nucleotides 530 and 912), which form interactions with the S12 
protein.
79,145,160
 One of them, the G524C mutation, severely disrupts 524G 
and 507C, a Watson-Crick type action that is essential to ribosomal function. 
The nucleotide mutation previously described at position 491 of the 
rrsgene, in two strains resistant to streptomycin,
221
 is a polymorphism that is 
not related to resistance. 
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A 30% of STR resistant strains do not have a mutation in the rpsL or 
rrs genes. Resistance could be caused by membrane impermeability.
192
 
Recently, it has been suggested that mutations in gidB, encoding a 
conserved 16S RNA specific 7-methylguanosine methyltransferase, or the 






2.2.5. Main lineages within M. tuberculosis species 
Within the scope of this chapter is the description of the results of the 
molecular population approach that allowed the definition of genetically 
homogenous clusters of M. tuberculosis complex, which are now to be 
preferentially lined to some human hosts.
27.83
 Table 4 provides the latest 
description of statistically, epidemiologically or phylogeographically 
relevant clonal complexes of M. tuberculosis complex based on 
spoligotyping signatures described in the SpolDBa database (a high 




Table 4. Comparision of spoligotype, Multi Locus Sequence Typing (MLST) 







































West African 1 
West African 2 
Prevalent in Sout East 
Asia, East Africa and 
South India 
Prevalent in China, 
Japan, South East Asia, 
Russia 
Prevalent in North 
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Principal lineages of the Genetic group 1 
 
The East African-Indian (EAI) lineage 
This lineage was first described in Guinea-Bissau
105
 and was shown to be 
fequent in South-East-Asia, India, and East Africa
118
. This group of strains is 
characterzied by a low number of IS6110 copies. A subgroup of these strains 
harboring a single copy of IS6110 was showed to be widespread in Malaysia, 
Tanzania, and Oman.
82
 In combined datastes (i,e, pooled datasets charcterised 
by one ore more methods), this lineage demonstrated congruence between 
spoligotypes (absence of spacers 29-32, presence of spacer 33, absence of 
spacer 34), VNTR [extract tandem repeat A (ETR-A) allele ≥4], katG-gyrA 
grouping (Group 1), and later the presence of the TbD1 sequence.
211
 More 
recently, the presence of an oxyR C37T transition was showed to be specific the 
lineage.
11
 This lineage was showed to belong to cluster group 1 or Cluster I.
77
 It 
harbors a specific region of difference, RD239 and was renamed as Indo-
Oceanic in the work of Gagneux et al.
83
 It is speculated that this lineage, which 
is endemic in South-East Asia, South-India, and East-Africa, may have 
orgirinated in Asia, where TB could have historically found favorable spreading 
conditions. The Manila family was first identified by Douglas in 1997, and was 
later thoroughly characterized by the same group.
61
 This genotype was 
identified based on the prevalence of clustered strains isolated from Philippino 
immigrants in the United States (US) and was only later showed to be  
prevalent in the Philippines. The Manila family bears ST19 as prototypic 
spoligo-signature and is actually identical to EAI-2.
76
 ST 89, which defines the 
Nonthaburi (Thailand) group of strains, is a derived clone.
161
 In this family, 
specific variants have been also described for Vietnam (ST139 or EAI-4). 
Bangladesh (ST591, ST1898 or EAI-6 and 7) and Madagasca (ST109, EAI-6). 
There is no precise idea about the prevalence of the EAI lineage in 
India and China, although it is evident that this genotype is more specifically 
linked with South-East Asia and South India than with Northern China.
177
 
This may be due to differences in civilization and agriculture histories 
between North and South China.
215
 It is also difficult to analyze what links 
these clones may have with strains in the major genetic group 2, given the 
presence of the spacer 33 in this group of strains (a spacer that is absent in 
group 2 and 3). A striking discovery related to these strains was made 
recently when analyzing medieval human remains discovered in an English 
parish. TB was confirmed by amplifying multiple M. tuberculosis loci and 
EAI genotypes were apparently identified by spoligotyping.
230
 Whether these 
spoligotyping results obtained on medieval remains are reliable or not should 
be confirmed independently; however, the posibility of the presence of EAI 
genotypes in 13
th
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The Beijing lineage 
The Beijing genotyping belongs to the the principal genetic group 1 of 
Sreevatsan, and its specific spoligotype signature (absence of spacer 1-33, 
presence of spacer 34-43) was discovered in 1995.
248
 However, a notorious 
outbreak due to a multidrug resistant clone of one of its offspring (New York 
W strain) had been characterized earlier, at the beginning of ‟90s.22,184 The 
emergency of this family of related genotypes continues to pose a serious 
threat to TB control due to its high virulence and frequent association with 
multidrug resistance. It was hypothesized that this genotype emerged 





 However, Beijing should also be considered as a group of 
variant clones that evolved from a common precursor at undefined time, 
maybe during the Genghis Khan reign or before.
152 
These strains are characterised by the presence of an inverted IS6110 
copy within the DR region, an IS6110 element at a particular insertion site 
(within the origin of replication) and one or two IS6110 copies in DNA region 
called NTF.
184,120
 A characteristic Beijing lineage-defining SNP (G81A in 
Rv3815c) has been reported by Filliol et al. According to SNP analysis, the 
Beijing cluster was designated as SCG 2 or sSNP-II.
77
 Other characteristic 
sSNPs of the Beijing lineage were described in putative DNA repaire genes.
186
 
More recently, new phylogenetically informative specific LSP markers 
were found, such as RD105, which is present in all Beijing/W or RD142, 
RD150, and RD181. It allows a futher division of the Beijing lineage into four 
monophyletic subgroups.
242
 The Beijing lineage was recently renamed as the 
East Asian Lineage by other authors.
83




Recent evidence points to an early dispersal of the Beijing genotype in 
correlation to genetic haplotype diversity of the male Y chromosome (i.e. in 
correlation with human phylogeography). These results susgest that the 
spreading history of Beijing has a molecular evolutionary history that is much 
more intricate and more deeply rooted to human history than initially thought. 
Using the Beijing genotype as a model, and comparing its phylogeography to 
Y-chromosome-based phylogeography, Mokrousov et al. hypothesized that 
two events shaped the early history of this genotype: (1) its upper Paleolithic 
origin in the Homo sapiens sapiens K-M9 cluster in central Asia, and (2) a 
primary dispersal of the secondary Beijing NFT::IS6110 lineage by Proto-
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The Central-Asian (CAS) or Delhi lineage 
The presence in India of a specific lineage of the M. tuberculosis 
complex was concomitantly and independently reported by two different 
groups using IS6110 RFLP and spoligotyping, respectively.
21,75
 This lineage 
was also shown to be endemic in Sudan, other sub-Sahara countries and 
Pakistan.
27
 Using IS6110 RFLP, the Delhi lineage shows a characteristic band 
pair in the high molecular weight region (12.1 and 10.1 kilobase pairs) and its 
specific spoligotype signature is formed in the absence of spacers 4-27 and 23-
34. This spoligo-signature shows numerous variants and several subgroups 
such as CAS1-Kili (for Kilimanjaro) and CAS1-Dar (for Dar-es-Salaam), 
which have already been defined on the basis of new spoligotype-signatures 
that are specific for each new clonal complex.
70,143
 Still, more results using 
other polymorphic markers should complement these data. VNTR signatures 
of M. tuberculosis complex clinical isolates from South-Asian immigrants in 
London and native patients in Rawalpindi, Pakistan, were identical 
(allelecombination 42235) and correlated with the CAS spoligotype.
85
 
This genotype family could be the ancestor of the Beijing family since 
it clusters close to Beijing when analyzed by a combination of MIRU, 
spoligotyping and VNTR.
214
 In India, its fequency varies from one region to 
another: it is more prevalent in the North than in the South, where the EAI 
family predominates.
227
 An outbreak strains named CH  was recently 
reported in Leicester, United Kingdom. It belongs to the CAS family and 
harbors a specific delection (Rv1519). In broth media, this strain was found 
to growmore slowly and to be less tolerant to acid and H2O2 than two 
laboratory reference strains, CDC1551 and H37Rv. Nevertheless, its ability 
to grow in human monocyte-derived macrophages was not impaired. This 
strain included more anti-inflammatory IL-10, more IL-6 gene 
transcription/section from monocyte-derived macrophages, and less 
protective IL-12p40 than CDC1551 and H37Rv strains. Thus, this strain 
seem to compensate the microbiological attennuation by skewing the innate 
response toward a phagocyte deactivation. These results suggest that the 
Rv1519 polymorphism confers an immune subverting M. tuberculosis 




Lineages belonging to the Princilap Genetic group 2 and 3 
The Haarlem family 
The Haarlem family was described in the Netherland in 1999.
118
 On 
IS6110 RFLP, these strains harbor a double band at 1.4 kb. Their spoligotype 
is characterized by the absence of the spacer 31, which is due to the presence 
of a second copy of IS6110 in the DR region.
89
 Due to an asymmetric 
insertion within the DR locus, this second IS6110 copy hinders the detection 
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 Three main spoligotype-signatures define the variants H1 
to H3.
76
 However, many Haarlem clonal complexes may harbor other 
Haarlem-based spoligotype-signatures that are, as yet, poorly characterized. 
Another characteristic of the Haarlem lineage is the frequent VNTR pattern 
33233.
118
 The Haarlem family is highly prevalent in Northern Europe. It is 
present in the Caribbean to a lesser extent and is also prevalent in Central 
Africa, where it is believed to have been introduced during the European 
colonization.
75
 This family, which is highly diverse, merits futher studies to 
better understsand its evolutionary history. A SNP in the mgt gene of the M. 
tuberculosis Haarlem genotpe was discovered recently.
4
 More SNPs are 
expected to be specific of the Haarlem lineage.
177 
 
The Latin American and Mediterranean (LAM) family 
The LAM family was defined by the finding of linkage disequilibrium 
between the absence of spacers 21-24 in the spoligotyping and the presence 
of an ETR-A allele equal to 2.
215
 However, this genotype family is more 
diverse and its study is more complicated than initially thought. Strains 
belonging to the LAM3/F11 family and the S/F28 family harbor identical 
spoligotypes of the shared type ST4, revealing the existence of genetic 
convergence between spoliotypes.
256
 This phenomenon seems, however, to 
be rare and highly dependent on the structure of the observed spoligotype. 
The absence of spacer 21-24 may also have occurred more than once in 
tubercle bacilli evolution although no genetic evidence has suggested such a 
convergence event untill now. Many sub-motifs - LAM1 to LAM12 - have 
been suggested according to the latest international spoligotype database 
project SpolDB4.
27
 However, the phylogenetic significance of the common 
absence of spacers 23-24 has not been demonstrated in this lineage. In this 
sense, some genotypes that showed strong geographical specificity (for 
example the LAM10-Cameroon or the LAM7-Turkey) were initially labeled 
as LAM, although there is no evidence of their phylogenetical relation to 
other LAM spoligo-signature.
169,276
 Recently, a specific deletion designated 
as RD
RIO 
was showed to be linked to certain LAM spoligo-signatures present 




The LAM clade is frequent in Mediterranean countries and its 
presence in Latin America is supposed to be linked to the Lusitanian-
Hispanian colonization of the New World. Conversely, it may have been 
endemic in Africa and/or in South America, spreading to Europe later. At 
this stage, we must highlight that paleopathological  and ancient DNA data 
support the existence of TB before the arrival of Spanish settler to Latin 
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The X family: the European IS6110 low banders 
The X family of strains is defined by two concomitant features, a low 
number of IS6110 copies and the absence of spacer 18 in the 
spoligotyping.
204
 This latter is indeed an important characteristic common to 
at least three spoligotype shared types: ST119, ST137, and ST92. Both 
characteristics are present in the CDC1551 strain, which are once suggested 
to be highly virulent. The X family was also the first group identified in 
Guadeloupe 
216
 and the French Polynesia.
237
 Specific epidemic variants of 
this genotype family were described in South Africa.
223
 The absence of 
spacer 18 bears phylogenetical significance because it is improbable that this 
spacer was delected more than once in this evolution of M. tuberculosis. This 
distribution of X family appears to be linked to Anglo-Saxon countries.
49
 It 
is also highly prevalent in South Africa and to a lesser extent in the 
Caribbean. Currently, it is only poorly documented in India. The strong 
presence of this genotype family in Mexico could be explained by its close 
proximity to the USA.
177 
 
The T families and others 
The „‟ill-defined‟‟ T group is characterized „‟by default‟‟. It includes 
strains that miss spacers 33-36 and can hardly be classified in other groups. 
This is a general characteristic of strains belonging to the principal genetic 
groups 2 and 3, together with the absence of an intact pks 15/1 gene.
135
 The 
presence of intact polyketide synthase genes, active in the synthesis of the 
specific lipid complex of the M. tuberculosis complex is known to be linked 
to virulence.
47
 Conversely, the 7 bp frameshift delection in pks15/1 may be 
considered as a phylogenetical marker specific for the modern M. 
tuberculosis strains
83
 and may define the recently designatured Euro-
American lineage. It is expected that the combination of spoligotype and 
improved MIRU signatures will be the best way to precisely define 
epidemiological clonal complexes.
226
 Alternatively, RDs and/or SNPs may 
also improve the taxonomic definition of these clones. 
Table 4 shows the nomenclature correspondence between the main 





. As shown, spoligotyping appears to be more 
discriminative than the other two typing systems since it is able to resolve 
clinical isolates within the branch of the modern strains that are not solved 
by LSP. Specific RDs are described for many individual spoligotype-
signatures; however, no Table is yet available for LSP and/or SNP synthetic 
correspondence with spoligotype. 
Even if there is consensus in the fact that the main branches of the 
genetic tree of the M. tuberculosis complex have now been found, many 
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uncertainties still remain with regard to the chronology of the evolution of 
the M. tuberculosis complex. For example, Gagneux et al. suggest that West 
African 2 diverged from an ancestral branch of M. bovis, whereas West 





 have shown that, in certain cases, it should be 
possible to reconstruct the past evolutionary history of some modern clones 
of the M. tuberculosis complex belonging to the principal groups 2 and 3. As 
an example, a striking identity was found recently between the MIRU typing 
results of the mains LAM7-Turkey clonal complex
276
 and the Japanese group 
T3-OSA.7 The meaning of this identity is under investigation and there is no 
reason to believe that it is due to convergence. Similarly, an endemic clone 
found in Nunavik
166
 was shown to be related to a clone found to be prevalent 
in central Europe (Poland and Germany).  
Brudey et al.
27
 data-mined an updated international spoligotype 
database of the M. tuberculosis complex, SpolDB4, both for improving 
classification of M. tuberculosis complex genomes, and for presenting a 
more reliable snapshot picture of the global and local population genetics of 
tubercle bacilli. Considering the known diversity of the origin of patients, 
SpolDB4 represents clinical isolates from a total of 141 countries.  
However recent studies from different regions
15,238
 have shown that 
several spoligopatterns could not be typed on the basis of  the existing 
SpolBD4 database. This indicates the current absence of knowledge on the 
genetic diversity of M. tuberculosis strains from those regions. This therefore 
calls for more clinical epidemiological studies in different regions to clearly 
understand the genetic diversity of the TB epidemic on the continent. 
In a more recent research, Brown et al
26
 showed the strong 
associations between patient‟s country of origin and the spoligo family of the 
isolate: CAS and EAI families dominated in patients born on ISC (RR 2.4, 
95% CI 2.02–2.74) as did Beijing and EAI families in patients born in South 
East Asia (RR 4.8, 95% CI 2.70–8.54). EAI families were seen in 80.4% of 
isolates from patients born in East Africa andhe ISC. The M. africanum 
family dominated in patientsborn in West Africa (RR 3.67, 95% CI 1.52–
6.50). In contrast, LAM and Haarlem isolates were infrequently seen 
inpatients born on the ISC (4.5% and 5.4%) and SoutheastAsia (3.4% and 
6.9%). T family isolates, one of the genetic groups determined by 
spoligotyping, were distributed evenly across all regions except Southeast 
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3. RESEARCH OBJECTIVES 
 
 
Tuberculosis remains a major cause of morbidity and mortality in 
many countries and a significant public health problem worldwide. The 
emergence of drug resistant strains and particularly multidrug-resistant 
strains of Mycobacterium tuberculosis, has become a significant public 
health problem in a number of countries and an obstacle for an effective 
control of tuberculosis. 
Vietnam is a high burden country for tuberculosis.
260
 In Vietnam, almost 
30,000 people die every year  from TB (one death every 18 minutes). Vietnam, 
with its estimated 175,000 new cases per year (or 201 cases per 100,000 
population) ranks 12th among the 22 countries
262
 which added together account 
for 80% of the global TB burden, with a prevalence of smear-positive 
tuberculosis of  89 per 100,000 population (WHO, unpublished data, 2008). If 
TB is detected early and properly treated using a combination of medicines for 
6 to 9 months, the patients quickly become non-infectious and are eventually 
cured. Multi-drug resistant TB (MDR-TB) and extensively drug-resistant TB 
(XDR-TB), HIV-associated TB and weak health systems are major challenges 
in Vietnam. There are an estimated 7,000 new MDR-TB cases and 6,400 new 
TB/HIV cases every year. Both of these forms of complicated TB carry a high 
risk of early mortality.
262
 The National Tuberculosis Control Programme is well 
established and has nationwide coverage.
98
 
Although tuberculosis is still a public health problem in Vietnam, 
there is little information about the genetic characteristics of the isolates. A 
better knowledge of the molecular characteristics of M.tuberculosis strains 
will contribute to understand the transmission dynamics of the disease within 
the country.  
 The overall objective of this study isto determine the molecular 
epidemiology and the phenotypic and genetic characteristics of mycobacteria 
isolated in central Vietnam. 
The specific objectives are:  
 to determine the rate of drug-resistant and multidrug-resistant 
M.tuberculosis strains. 
 to detect tuberculosis by using the PCR assay and determine the rate of 
M.tuberculosis strains which do not harbor insert sequence IS6110. 
 to determine with molecular epidemiology methods  the distribution of 
genotypes and  create a phylogenetic tree of isolated M. tuberculosis 
strains. 
 to describe the molecular characteristics of a representative multidrug-
resistant M. tuberculosis strain isolated in centralVietnam. 
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4. MATERIALS AND METHODS 
 
 
4.1. Study design 
This was a cross-sectional study and was conducted from July 2009 to 
June 2011, at the Carlo Urbani Centre, Department of Microbiology, Hue 
College of Medicine and Pharmacy, in Central Vietnam. 
4.2. Enrollment 
Patients suspected or confirmed of having tuberculosisat the Hospital 
of Hue College of Medicine and Pharmacy, Hue Central Hospital and 
Danang Lung Hospital, in Central Vietnam were enrolled into the study.  
All patients were from a single ethnicity (Vietnamese Kinh).  
Any patient already receiving TB therapy for more than two weeks 
was excluded from the study.  
Samples were collected as per routine care as deemed appropriate by 
the treating physician. All specimen types from suspected cases were 
included in the study. 
Data on socio-economic and demographic features, TB history, HIV 
status and presenting clinical features were prospectively collected on a case 
report form. 
Written informed consent was obtained from all participants and the 
study was approved by the ethics committee of Hue College of Medicine and 
Pharmacy. 
 
4.3. Specimen preparation and examination 
 
Ziehl-Neelsen staining 
All specimens were processed for acid fast microscopy and reported 
according to guidelines of WHO.
258
 
The smear is flooded entirely with concentrated fuchsin solution and 
heated using a spirit lamp from beneath, flaming must be stopped once 
fumes arise and allowed to cool in 5 minutes. The solution is then poured off 
and washed in gentle stream of running tap water. The smear is then covered 
with few drops of 3% acid-alcohol and allowed to act for a maximum of 3 
minutes and then washed in tap water. The process of decolorisation will be 
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repeated until the smear is faintly pink or almost colorless. The smear is then 
washed in water and counterstained with methylene blue solution and 
allowed to act for 60 seconds. The slide is then washed in water and dried 
with blotting paper and observed under oil immersion objective. 
A positive sputum sample typically contain pink colored, rod shaped 
bacteria that are slightly curved, sometimes branching, sometimes beaded in 
appearance, present singly or in small clumps against a blue background of 
pus cells and epithelial cells. 
 
Specimen decontamination 
All specimen, except for cerebral spinal fluid (CSF), were 
decontaminated. Specimens were digested and decontaminated of other 
bacteria by the standard N-acetyl-L-cysteine-sodium hydroxide method.
119
  
An equal volume of fresh 4% sodium hydroxide-N-acetyl-L-cysteine (NALC 
-NaOH) solution was added to each specimen in a sterile 50 ml conical 
screw-top centrifuge tube. The tube was tightly closed, inverted and   on the 
vortex, then incubated at room temperature for exactly 15 min, followed by 
dilution up to 45 ml with phosphate buffer saline (PBS). After centrifugation 
at 3000 g for 15 min, the supernatant was decanted. Pellets were resuspended 
in a final volume of 2 ml and used for the inoculation of culture media and 
PCR assay. 
For CSF samples, the sample tubes were centrifuged at 3000 g, 4
o
C 
for 20 minutes (Eppendorf). After discarding the supernatant, 2 ml pellet was 
used for smear and PCR assay. 
 
4.5. The Microscopic-Observation Drug-Susceptibility (MODS) assay 
The MODS assay for the detection of tuberculosis and multidrug-
resistant tuberculosis, directly from sputum, relies on three principles: first, 
that Mycobacterium tuberculosis grows faster in liquid medium than in solid 
medium; second, that characteristic cord formation can be visualized 
microscopically in liquid medium at an early stage; and third, that the 
incorporation of drugs permits rapid and direct drug-susceptibility testing 
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Figure 6: The MODS assay flowchart 
 
 
The MODS assay was performed in 24-well tissue-culture plates 
(Corning) as described in previous protocols,
48,155
 with some modifications. 
Antibiotic stock solutions were diluted from isoniazid (INH), rifampicin 
(RIF), streptomycin (STR) and ethambutol ((EMB) powder and added to 
liquid medium to give the following critical concentrations: INH, 0.1 and 0.4 
µg/ml (MODS INH medium); RIF, 1 and 2 µg/ml (MODS RIF medium); 
STR, 2 and 6 µg/ml and EMB, 2.5 and 5 µg/ml. Specimens obtained from 
different subjects but processed on the same day were plated into different 
rows of the same plate. To minimize cross contamination and occupational 
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exposure, plates were permanently sealed inside plastic zip lock bags and 
were subsequently examined within the bag, the plates were incubated at 
37°C. On each processing time, H37Rv strain was used as a drug-sensitive 
postive control. Wells containing decontaminated sample, 7H9-OADC, and 
PANTA, with or without drug, were examined daily (weekdays only) from 
day 5 to 15, on alternate days from day 16 to 25, and twice weekly from day 
26 to 40 under an inverted light microscope at 40x magnification.  
Positive cultures were identified by cord formation, characteristic of 




Drug-containing wells were recorded as positive (indicating drug 
resistance) if corded growth was visible and negative (indicating 
susceptibility) if no corded growth was visible.  
Nontuberculous mycobacteria could be recognized by their lack of 
cording or, for M. chelonae (which is the only nontuberculous mycobacteria 
that does form cords), by rapid overgrowth by day 5.
155 
The samples corded growth of which was visible by day 5 or earlier or 
the samples which were smear positive but no corded growth was visible, 
were retested by the 16S rRNA gene realtime PCR specific for 
M.tuberculosis complex. 
 
4.6. DNA extraction 
 
Extraction of DNA from clinical samples 
DNA was extracted from the samples by DNeasy Blood & Tissue kit 
(Qiagen). Before performing DNA extraction, 500 µl of decontaminated 
samples were incubate at 95
o
C for 20 minutes to kill bacteria. Samples are 
first lysed using proteinase K, incubate at 56°C overnight. Add 200 μl of 
buffer AL add 200 μl of ethanol (96%). Transfer this mixture into the 
DNeasy Mini spin column placed in a 2 ml collection tube. During 
centrifugation, DNA is selectively bound to the DNeasy membrane as 
contaminants pass through. Remaining contaminants and enzyme inhibitors 
are removed in two efficient wash steps with buffer AW1 and AW2. Purified 
DNA is then eluted in 100 µl buffer AE . 
 
DNA extraction from isolated mycobacterial strains by using 
Cetyltrimethyl Ammonium Bromide (CTAB) 
24 hour before harvesting the cells for genomic DNA preparation, add 
glycerine to a late-log-phase culture to a final concentration of 1% using a 
10% (wt/vol) glycine stock, incubate at 37
o
C. 
Transfer 10 ml of culture to a 15 ml conical tube and spin in a 
centrifuge at 2,000 x g for 20 min. Centrifuge bacteria andre-suspended in 50 
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overnight, then add 100 µl of 10% SDS and 50 µl of 10 mg/ml proteinase K, 
incubate at 55
o
C for 20-40 min to process the resistant cell wall. After 
incubation, add 200 µl of 5M NaCl and 160 µl of CTAB, this step is 
conducted at 65°C for 10 min, to precipitate proteins and macromolecules. 
Subsequently, DNA is purified by extraction with an equal volume of 
chloroform-isoamyl alcohol (24:1). This step was repeated twice. After the 
last step of extraction is completed, DNA is precipitated with isopropanol 
and mix gently by inversion until the DNA has precipitated out of solution, 
incubate at room temperature for 5 min. After centrifugation, DNA is 
washed from the pellet with 70% ethanol, air-dried and eluted in 50 µl of 
water and store at 4
o
C to allow pellet to dissolve overnight.
93 
 
4.7. Polymerase chain reaction (PCR) assay 
In this study, insertion sequence IS6110 based nested PCR (IS6110 
PCR) assay and 16S rRNAgene TaqMan based realtime PCR (16S rDNA 
PCR) assay were combined for detecting the absence of IS6110 sequence in 
M. tuberculosis strain. 
The performance of 16S rDNA PCR was assessed in 480clinical 
specimens including sputum, bronchial lavage, pleural fluid, cerebral spinal 
fluid (CSF), and others (gastric fluid , joint fluid, blood, abscess). All 
samples which were positive with the 16S rDNA PCR assay were retested in 
IS6110 PCR assay to detect the deletion of the insert sequence IS6110.  
 
The 16S rRNA gene TaqMan based realtime PCR (16S rDNA PCR) assay 
The amplified target is part of the 16S rRNA gene which is common 
to all the mycobacteria. The discrimination between the members of the M. 
tuberculosis complex and the other mycobacteria requires an additional step 
that involves DNA hybridization.
117,234
 
LightPower iVAMTB rPCR Kit (from VietA Company, Vietnam) is a 
qualitative realtime PCR assay which identify the members of the M. 
tuberculosis complex; the target used in this procedures is the 16S rRNA 
gene in association with the insertion sequence IS6110 to increase the 
sensitivity of the assay. 
For the target 16S rRNA gene, a pair of unlabeled Mycobacteria 
specific PCR primers, the product of which is 95 bp in length, and a M. 
tuberculosis specific TaqMan probe with a FAM dye label on the 5' end, and 
non-fluorescent quencher dye (TAMRA) on the 3' end are designed. 
PCR amplifications were carried out in 25µl reaction mixtures by 
adding 5µl of template DNA to 20µl of a premade amplification master 
mixture. Target DNAs were amplified in a thermal cycler (Stratagene Mx 
3000, USA) as follows: initial denaturation at95°C for 5 minute, this was 
followed by 40 cycles, each cycle consisting of 15 seconds at 95°C, 1 minute 
at 50°C and 20 seconds at 72°C and then 10 minutes at 72°C. 
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The IS6110 based two-stepnested PCR (IS6110 PCR) assay 
The IS6110 nested PCR assay was performed with an in-house kit, 
following the protocol of tuberculosis laboratory of Section of Experimental 
and Clinical Microbiology, Department of Biomedical Science, Sassari 
University. 
Two sets of primers IS1, IS2 and IS3, IS4 (as described in the 
appendix) were used to amplify 300 bp fragment of insertion element IS6110 
of M. tuberculosis complex. The extracted DNA was amplified by two step 
PCR assay. The amplification was carried out in a thermocycler (Veriti™ 
96-Well Thermal Cycler, Applied Biosystems). 
- In the first step, a DNA segment was amplified by external primer 
(IS1, IS2). The first amplification carried out in 30μl final volume, in which: 
PCR Master Mix (2X) 12.5 µl 
IS1 primer (10 µM) 1.0 µl 
IS2 primer (10 µM)   1.0 µl 
MQ water     5.5 µl 
DNA template  10.0 µl 
Target DNAs were amplified in a thermal cycler (Stratagene Mx 3000, 
USA) as follows: after initial denaturation at 94°C for 5 minute, 36 amplification 
cycles were performed within thermocycler. Each cycle consisting of 
denaturation at 94°C for 50 seconds, annealing of primer at 58°C for 50 seconds 
and primer extension at 72°C for 50 seconds; then and a final extension at 72°C 
for 10 minutes. After complete amplification, the amplified product was used as 
DNA template for second amplification of 300 bp segments.  
- In the second step, the first PCR product was amplified by internal 
primer (IS3, IS4). The second amplification carried out in 25μl final volume, 
in which: 
PCR Master Mix (2X) 12.5 µl 
IS3 primer (10 µM)   1.0 µl 
IS4 primer (10 µM)   1.0 µl 
MQ water     5.5 µl 
The first PCR product   5.0 µl 
The second amplification was carried out as follows: at94°C for 5 
minute, 36 amplification cycles of at 94°C for 50 seconds, at 60°C for 50 
seconds and primer extension at 72°C for 50 seconds; and then at 72°C for 
10 minutes. 
The second PCR products were analyzed by gel electrophores is in 2% 
agarose  prepared in TBE buffer containing 0.5µg/ml of ethidium bromide 
(Sigma). The gel was examined in a gel documentation system (Bio-Rad) for 
a 300 bp using standard molecular marker (100 bp DNA Ladder). Presence of 
a band equivalent to 300 bp was taken a positive result when negative control 
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Throughout PCR processing the three room procedure and other 
recommended stringent precautions were followed and the results were 
evaluated in the light of the performance of appropriate positive and negative 
controls, to avoid cross-contamination and false positive reactions. 
 
4.8. Spoligotyping (spacer oligonucleotide typing) 
This is a PCR-based method, which depends on the amplification of a 
highly polymorphic Direct Repeat (DR) locus in M. tuberculosis genome. 
The DR region in M. bovis BCG contains direct repeat sequences of 36 bp, 
which is interspersed by the non-repetitive DNA spacers of 35-41 bp in 
length. In other M. tuberculosis complex strains, the number of DR elements 
vary significantly and majority of the M. tuberculosis strains contain one or 
more IS6110 elements in DR region. 
The performance of spoligotyping was assessed in 122 DNA samples. 
M. tuberculosis strain H37Rv and M.bovis BCG P3 were used  as positive 
controls and water was used as a negative control. 
M. tuberculosis strains were genotyped by spoligotyping using the 
standardized method as follows: 
 
Amplification of spacer DNA by PCR 
Prepare the reaction mixture: 
2 μl template DNA 
3 μl primer DRa (0.2 μmol/μl) 
3 μl primer DRb (0.2 μmol/μl) 
20 μl 2×TaqPCR MasterMix 
12 μl MQ water (to a final volume of 40 μl) 
Perform the amplification in a thermocycler by the following 
temperature cycling: at 94°C for 3 minutes, then 25 cycles, each cycle 
consisting of at 94°C for 1 minute, at 55°C for 1minute and at 72°C for 30 
seconds; and then a final extension at 72°C for 1 minutes.  
 
Hybridization with PCR product and detection 
◦ Add 25 μl of the PCR products to 150 μl 2×SSPE/0.1 % SDS.Heat-
denature the diluted PCR product for 10 min at 99°C and cool on ice 
immediately. 
◦ Wash the membrane for 5 min at 60 °C in 250 ml 2×SSPE/0.1 % SDS. 
◦ Place the membrane and a support cushion into the miniblotter, in 
such a way that the slots are perpendicular to the line pattern of the 
applied oligonucleotides. 
◦ Remove residual fluid from the slots of the miniblotter by aspiration. 
◦ Fill the slots with the diluted PCR product (avoid air bubbles) and 
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hybridize for 60 min at 60 °C on a horizontal surface (no shaking). 
Avoid contamination of neighbouring slots. 
◦ Remove the samples from the miniblotter by aspiration and take the 
membrane from the miniblotter using forceps. 
◦ Wash the membrane twice in 250 ml 2×SSPE/0.5 % SDS for 10 min 
at 60 °C. 
◦ Place the membrane in a rolling bottle and allow it to cool down to 
prevent inactivation of the peroxidase in the next step. 
◦ Add 2.5 μl streptavidin-peroxidase conjugate (500 U/ml) to 10 ml of 
2×SSPE/0.5 % SDS, and incubate the membrane in this solution for 
60 min at 42°C in the rolling bottle. 
◦ Wash the membrane twice in 250 ml of 2×SSPE/0.5 % SDS for 
10 min at 42 °C. 
◦ Rinse the membrane twice with 250 ml of 2×SSPE for 5 min at room 
temperature. 
◦ For chemiluminiscent detection of hybridizing DNA, incubate the 
membrane for 1 min in 20 ml ECL detection liquid. 
◦ Cover the membrane with a transparent plastic sheet and expose a 
light sensitive film to the membrane for 3hours. 




Genotypes were defined as spoligotyping signatures described in the 
SpolDB4 (a high resolution image can be downloaded at: 
http://www.biomedcentral.com/1471-2180/6/23/figure/F1?highres=y; from 
Brudey 2006). 
Spoligotypes were assigned to families and subfamilies by using the 
Spoligodb Lookup Tools, which was established by Nguyen Hoang Bach, at 
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4.9. Whole genome sequencing 
- One strain of M. tuberculosis (MTB_HUE_20 strain ) was choosen to re-
sequencing whole genome based on paired-end sequencing on the Illumina 
GAIIx platform. 
- This strain had the following characteristics:  
◦ was isolated from a smear-positive sputum specimen of a 47-year-old 
male patient with typical clinical features of tuberculosis. This patient 
didnot have previous tuberculosis disease. 
◦ resistance to rifampicin, isoniazid (multidrug resistance) 
◦ positive with IS6110 PCR 
◦ its spoligotyping pattern does not match with any described genotye in 
the SpolDB4 database (unknown genotype) 
 
- Thirty microgram of the genomic DNA was purified by CTAB method and 
sent to BaseClear Co. DNA Sequencing Service in the Netherlands to 
perform the sequencing.  
- The type of sequence run is paired-end with 75 bp read length. 
- We received about 300 MB of DNA sequencing data in paired-end reads 
from the Illumina platform. That is the raw sequence data in FASTQ format. 
- Analysing: De Novo genomic assembly was performed with Velvet 
program.
271
 Gene prediction and translate predicted genes into proteins with 
GeneMarkS.
19
 Annotate all ORFs obtained with Blast2Go program 
[blast2go]. Create GFF file to annotate circular genome MTB_HUE_20 
strain with Geneious software.
63 
 
4.10. Data processing 
◦ Statistical analysis was performed using Medcalc software. 
◦ Comparison of  proportions between two groups of patient was done 
with Fisher‟s exact test. 
◦ Odds ratio was used to predict the ratio of the odds of drug resistance 
occurring in spoligotype groups. 
◦ All reported confidence interval are two-sided 95% confidence intervals 
and p-values <0.05 were regarded as statistically significant.  
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5.1. Proportion of culture positivity and drug susceptibility of M. 
tuberculosis isolates from the MODS assay 
 
The MODS assay was performed for 305 sputum samples of patients 
with suspected or confirmed tuberculosis. A total of 53 (17.4%) samples, in 
which contamination in the cultured sample was observed, were excluded 
from the study. Data of 252 remaining patients were included in the analysis. 
In brief, the male: female ratio was 1: 2.5, the median age was 47.5 ± 19.3 
(min 18, max 93). In 224 (98.9 %) patients new tuberculosis was suspected 
and 28 (11.1%) were previous tuberculosis patients. Ziehl-Neelsen AFB 
staining was positive in 155 (61.5%) of samples. 
Among 252 MODS cultured samples 153 (60.7%) were positive for 
M. tuberculosis which was identified by the cord formation (Figure 7). The 
proportion of culture positive samples in the group of patients suspected of 
new tuberculosis and in the group of previous tuberculosis patients were 
57.9% and 85.7%, respectively. The prevalences of smear - positive and 





Fifure 7. Corded growth  of  M. tuberculosis in MODS culture 
observed at 400 x magnification 
  
48 
Ngo Viet Quynh Tram - Molecular epidemiology and phenotypic and genetic characterization of 
Mycobacteria isolated in central Vietnam - Ph.D thesis in Clinical and Molecular Microbiology 
 of Ph.D School in Biomolecular and Biotechnological Science - University of Sassari 
 
 



























153 60.7 24 85.7 129 57.9 






















Figure 8. The proportion of smear - positive and MODS culture - positive 
samples according to the groups of patient 
 
In our study, 32.0% (31/97) of samples were culture positive but 
negative for AFB and 21.3% (33/155) of samples were AFB positive, but 
negative for culture  (Table 6 and Figure 9).  
The mean time for culture positivity and drug susceptibility testing 
using MODS assay were 9 days (range 5 to 17 days for culture and range 6 
to 14 days for drug susceptibility testing). 
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 No. of samples No. of samples No. of samples 
Positive 153 (60.7%) 122 (78.7%) 31 (32%) 
Negative 99 (39.3%) 33 (21.3%) 66(68%) 
























Figure 9. Proportion of positive samples with MODS culture according to AFB smear 
 
Drug susceptibility 
Among 153 culture-positive samples, the proportion of M. 
tuberculosis strains demonstrating sensitivity to all antibiotics (INH, RIF, 
STR and EMB) was 107 (69.9 %) and any drug resistance was 46 (30.1%). 
One drug resistance was observed in 30 strains (19.6%): 3.9%  for  INH, 
11.8% for RIF, 2.0% for STR and  EBM. Multidrug resistant M. tuberculosis 
as defined by WHO (resistant to RIF and INH) was observed in 8.5%. There 
were 9.2% of strains showing resistance to two or more drugs. The results of 
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patients (N =25) 

























 INH 0.1µg/µl 6 3.9 4 16.0 2 1.6 <0.01 
RIF  1.0 µg/µl 18 11.8 2 8.0 16 12.5 >0.05 
EMB 2.5µg/µl 3 2.0 0 - 3 2.3 - 
STR
 
2.0 µg/µl 3 2.0 0 - 3 2.3 - 
 MDR* 13 8.5 8 32.0 5 3.9 <0.01 
≥ 2 drugs 14 9.2 5 20.0 9 7.0 <0.01 
*MDR -/+ EMB and -/+ STR 
Two concentrations were examined for each drug, the second concentration, with no useful 

















Figure 10. Proportion of drug resistant M. tuberculosis according to patient group 
(DR: drug resistant) 
 
There was a statistically significant difference of drug resistance 
between the two groups of patients: the proportion of the strains which were 
resistant to any drug, INH, multidrug resistance and ≥ 2 drugs in the group of 
previous TB patients was higher than in the group of new tuberculosis 
suspected patients (p<0.01): 56% versus 25%, 16% versus 1.6%, 2% versus 
3.9% and 20% versus 7%, respectively. 
There was no significant difference of the drug resistance to RIF alone 
between the two groups of patients. Resistance to EMB and STR was not 
determined in the group of previous TB patients. 
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5.2. Results of PCR assay 
 
A total of 480 clinical samples of patients with suspected tuberculosis  
including sputum, bronchial lavage, pleural fluid, cerebral spinal fluid (CSF), 
and others (gastric fluid, joint fluid, blood, abscess) were assessed. The 
sputum specimens were the most common type of specimen (76 %). Positivity 
with  AFB staining was in 192 samples (40% of all types). No CSF specimen 
was positive with AFB. The AFB positivivity was detected in approximately 
50% of the sputum specimens (186/365) and in lower percentage in bronchial 
lavage (1/30 - 3.3%), pleural fluid (2/50 - 4%) and other specimens (3/25 - 
12%). The proportion of AFB positive samples is shown in Table 8. 
 
Table 8. Proportion of AFB positive samples 
 
Specimens AFB positive samples 
 no. % no. % 
Sputum 365 76.0 186 50.9 
Bronchial lavage 30 6.3 1 3.2 
Pleural fluid 50 10.4 2 4.0 
CSF 10 2.1 0 - 
Others 25 5.2 3 12.0 
Total 480 100 192 40.0 
 
 
The 16S rDNA PCR assay for 480 clinical samples detected 258 
positive cases (53.8%). A 3.6 % (7/192) of AFB-positive samples were 
negative. Furthermore the 16S rDNA PCR detected 73 cases (25.3%) of 
tuberculosis in AFB-negative samples, of which 54 (30.2%) were from 
sputum and  19 (17.4%) from the other type of specimens (Table 9 and 
Figure 11). 
 
Table 9. Results of  the 16S rDNA PCR according to AFB smear 
16S rDNA AFB smear 
Positive Negative 
 no. of sample no. of sample no. of sample 
Sputum 365 (100%) 186 (100%)  179 (100%) 
Positive 233 (63.8%) 179 (96.2%) 54 (30.2%) 
Negative 132 (36.2%)    7(3.8%) 125 (69.8%) 
Fluid and others 115 (100%)    6 (100%) 109 (100%) 
Positive 25  (21.3%)    6(100%) 19 (17.4%) 
Negative 90  (78.7%)    0      - 90 (82.6%) 
Total 480 (100%) 192 (100%) 288 (100%) 
Positive 258 (53.8%) 185 (96.4%) 73 (25.3%) 
Negative 222 (46.2%)    7 (3.6%) 215 (74.7%) 
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The performance of IS6110 PCR assay was assessed in a total of 258 
samples positive with 16S rDNA PCR. The result indicated that most of the 
processed samples (255, 98.8%) was positive with the IS6110 PCR product 
of 300 bp in lengh (Figure 12), and  only 3 samples (1.2 %)  were negative 




Figure 12. IS6110 PCR products of electrophoresed on 2% agarose 
M:DNA ruler of 100 bp, PC: positive control (H37Rv), NC: negative control, 
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5.3. The distribution of genotypes of isolated M. tuberculosis strains and 
the association between the genotypes and drug susceptibility 
 
The performance of spoligotyping assay for 122 samples which were 
identified as M.tuberculosis strains showed that EAI families dominated in 
our study. EAI genotypes were seen in 65.6% of isolates, of which 15.6% 
were of the EAI4-VNM genotype, and 46.7 % were of EAI5. Beijing 
genotype was observed in 12.3 % of isolates. There were 4 isolates (3.3%), 
of which spoligotype patterns did not match with any  of the updated 
international spoligotype database of the M.tuberculosis complex - SpolDB4, 
and were called Unknown (Unk) from 1 to 4. The remaining 22% were  of 
other genotypes (Table 10 and Figure 13). Spoligotyping produced a total of 
36 different patterns for the 122 strains studied (Figure 14). 
 




Spoligotype families and 
subfamilies 
No. of isolates 
N = 122 
n % 
EAI 80 65.6 
         EAI4-VNM 19 15.6 
         EAI5 57 46.7 
EAI1-SOM 3 2.5 
EAI2-NTB 1 0.8 
Beijing 15 12.3 
U 10 8.2 
T 6 4.9 
MANU 3 2.4 
H 3 2.4 
CAS 1 0.8 
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Figure 14. Spoligotype patterns of M. tuberculosis isolates. Spacers 1 to 43 are 
represented from left to right. A dendrogram created with Bionumerics software 
(neighbor joining; Euclidean distance) is presented on the left. Genotypes are identified 
on the right. 
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In the present study, there was no significant association of the Beijing 
genotype with resistance to drug since 20 % of Beijing isolates and 28.9% of 
non Beijing isolates were resistant to any first-linedrug (OR = 0.6 [95% 
confidence interval {CI}, 0.2 to 2.3]; P=0.47); 6.7% of Beijing isolates and 
10.3% of non Beijing isolates could be defined as multidrug resistance (OR 
= 0.6 [95% confidence interval {CI}, 0.1 to 5.2]; P=0.66).  
Similarly, there was no significant association of the EAI genotype 
with resistance to drug: 28.8 % of EAI isolates and 26.2% of non EAI 
isolates being resistant to any first-linedrug (OR = 1.1 [95% confidence 
interval {CI}, 0.5 to 2.6]; P=0.76); 8.6% of EAI isolates and 11.9% of non 
EAI isolates being multidrug resistance (OR = 0.7 [95% confidence interval 
{CI}, 0.2 to 2.4]; P=0.58). 
 
Table 11. Proportion of drug resistance of Beijing genotype and EAI 











Genotype n % n % 
Beijing 3 20.0 1 6.7 15 0.6 
0.2- 2.3 
0.6 
0.1 - 5.2 
Non Beijing 31 28.9 11 10.3 107 1 1 
EAI 23 28.8 7 8.6 80 1.1 
0.5- 2.6 
0.7 
0.2 - 2.4 
Non EAI 11 26.2 5 11.9 42 1 1 
 
 
5.4. Molecular characteristics of the MTB_HUE_20 strain 
 
De Novo and re-sequencing of M. tuberculosis genome 
(MTB_HUE_20 strain) have been performed. We selected the Illumina 
GAIIx platform. Using 20 µg of purified genomic DNA of M. tuberculosis 
HUE_20 strain, we have obtained about ~300Mb of high quality sequencing 
data in paired-end reads with 75bp reads length. 
 For De Novo assembly, Velvet currently takes in short read 
sequences, removes errors then produces high quality unique contigs. It then 
uses paired-end read to retrieve the repeated areas between contigs. With 
kmer=31, we obtained 1074 nodes with range length 94,000-100bp. 
We performed gene prediction and annotation on the obtained contigs, 
gene translation to protein and prediction of gene function with GenMarkS 
server, blast all open reading frames (ORFs) with NBCI server via Blast2Go 
Software. With a GFF file including the annotation, we built  a full sequence 
with annotation on all loci. 
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The full length of our strain is 4,397,928 bp with a high GC content of 
64.8% (Table 12, Figure 15). 
 
Table 12. Statistics of complete genome M. tuberculosis MTB_HUE_20 strain 
 
Base Frequency Percentage % 
A 776,371 17.7% 
C 1,434,609 32.6% 
G 1,416,809 32.2% 
T 770,139 17.5% 
GC 2,851,418 64.8% 




Figure 15. Visual full sequence of MTB_HUE_20 strain in circular mode 
 
Mapping reads to reference – Resequencing assembly 
 
 Use CLC Genomics Workbench 4.7.2 for mapping 3,857,132 
reads to refseq number NC_00962 (accession number PRJNA57777, ID: 
57777). We obtained a consensus sequence of MTB_HUE_20 strain 
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Table 13. Annotation types table on consensus sequence of MTB_HUE_20 
strain 
 
Annotation types Quality 
Gene 4062 
CDS (coding sequence) 4,003 
Mobile_element 56 
Repeat region 262 
rRNAgene (16S, 23S, 5S) 3 
tRNA gene 45 
 
 
We performed the SNP and DIP detection on mapped sequence. We 
found 2329 SNPs, including 1257 SNPs lead change of amino acid 
with coverage 4-221 and 159 DIPs with coverage range 4-123, of 
which 105 DIPs lead change of amino acid (Table 14). 
 
Table 14. Statistic of variation between MTB_HUE_20 and H37Rv strain 
 






SNP 2329 1 4-221 1257 




When mapping reads to the reference sequence (M. tuberculosis 
H37Rv complete genome with refseq number NC_00926), we found that 
there are 16 copies of IS6110 in H37Rv strain genome (Table 3 in appendix). 
Comparing the whole genomic DNA of MTB_HUE_20 strain with that of 
H37Rv strain, we determined the MTB_HUE_20 strain harbors one copy of 
IS6110 at position appropriate with locus_tagRv1755c of H37Rv strain, 
annotation of which is plcD gene, this ORF has been interrupted by insertion 
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MTB_HUE_20 strain is a MDR strain which was comfirmed by the 
MODS assay. Mutations in DNA-dependent RNA polymerase (rpoB) gene is 
among the most frequent in RIF-resistant strain 
231,232,272
 and catalase-
peroxidase (katG) gene in INH-resistant strain. 
92,102,188,192,272,274
  
So in this present study, we focused on analyzing rpoB gene and katG 
gene. 
Export rpoB sequence from full length genome obtained, the rpoB 
gene length of MTB_HUE_20 is 3518bp. We performed alignment with 
locus_tag Rv0667 of reference genome NC_000962.2 (Rv0667 is locus of 
rpoB gene of M. tuberculosis H37Rv). The percent of homology between 2 
sequences is ~99.98%, with 1 nucleotide different at position 3225: C in the 
MTB_HUE_20 strain versus T in H37Rv strain (Figure 17) 
Translate rpoB sequence of our strain to protein and do alignment of 2 
amino acid sequences, the percent of homology is 100%. Amino acid at 
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Figure 17. Nucleotide alignment of rpoB gene 
 
 
Figure 18.Protein alignment of rpoB gene 
 
When doing alignment of rpoB sequence of the MTB_HUE_20 strain 
with partial CDS of rpoB sequence of two M.tuberculosis strains (MDR-TB2 
and 331122070013) which were MDR strains with the mutation in rpoB 
gene, we found that there are 2 different nucleotides at position 1333 in 
strain 331122070013 (locus HQ844251.1) and at position 1334 (locus 
FJ915188.1) in MDR-TB2 strain (Figure 19). 
 
Figure 19.Nucleotide alignment of rpoB gene of 4 strains 
 
Protein alignment of 4 sequences showed difference at position 445 of 
1 amino acid: histidine (H) of  MTB_HUE_20 and H37Rv strains, versus 
arginine (R) of MDR-TB2 strain and aspartic acid (D) of 331122070013 
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Figure 20.Protein alignment of rpoB gene of 4 strains 
The katG sequence, obtained from full length genome, shows that the 
katG gene length of MTB_HUE_20 is 2223bp. We performed alignment 
with locus_tagRv1908c of reference genome NC_000962.2 (Rv1908cis 
locus of katG gene of M. tuberculosis H37Rv) and M. tuberculosis INH-
resistant strain H0169/93 (locus U41311.1). The percent of homology of 3 
sequences is ~99.96%, with 1 nucleotide different at position 1388, T in the 




Figure 21. Nucleotide alignment of katG gene 
 
 
Protein alignment of 3 sequences showed there is difference of 1 
amino acid at position 463: leucine (L) in the MTB_HUE_20 and H0169/93 
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6.1. Proportion of culture positivity and drug susceptibility of M. 
tuberculosis isolates from the MODS assay 
 
Early detection of drug resistance is the keypoint in effective control 
of drug resistant tuberculosis. Culture and drug susceptibility testing (DST) 
using conventional methods are time-consuming while automated methods 
tend to be expensive, limiting their use in resource constrained setting.
189,264
 
Hence there is need for a rapid, reliable and cost effective test for detection 
of drug resistance. MODS assay has the advantage of simultaneous detection 
and DST of M. tuberculosis.
129
 The greater sensitivity and speed of detection 
of MODS culture in comparison to gold standards were predicted on the 
basis of previous studies.
35,156
 
In the present study, among 252 MODS cultured samples, 153 
(60.7%) were positive for M.tuberculosis and they were  identified by the 
cord forming (Figure 7). The proportion of culture positive samples of the 
group of previous tuberculosis patients (85.7%) was higher than the group of 
patients suspected of new tuberculosis (57.6%). This difference was 
statistically significant (P<0.01; 95% CI)). The proportion of smear positive 
samples was 61.5% (155/252), similar to the proportion of MODS positive 
samples (60.7%). Interestingly, among the smear positive samples 21.3% 
(33/155) were negative for MODS culture, and among the smear negative 
samples 32% (31/97) were positive for MODS culture but negative for AFB. 
Of 33 culture negative and smear positive samples, 7 samples were negative 
for 16S rDNA PCR indicating non tuberculous mycobacteria. A previous 
study found that in sputum, the sensitivity of MODS was significantly higher 
than smear (P<0.001; 95%CI).
53
 The 26 remaining samples collected from 
patients receiving TB therapy for less than two weeks were positive for 16S 
rDNA PCR, indicating ability of killed bacteria. In a study of Kashmira 
Limaye et al.
129
 on new smear positive patients, the culture positivity rate 
was 100% (excluding contamination) for both MODS assay as well as 
Lowenstein medium. The high culture positivity rate in that study is due to 
the inclusion of only known smear positive patients. 
In a recent research in patients with confirmed or probable tuberculosis 
in South Vietnam
52
, MODS detected 72.8% (40/55) of Lowenstein-Jensen 
culture positive and smear negative tuberculosis cases. According to Moore et 
al.
156
 the detection rate of MODS among smear negative tuberculosis cases 
was 17.85%. In our study, we detected 32% (31/97) of  tuberculosis cases 
with smear negative samples. These results showed that MODS is useful for 
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detecting tuberculosis of smear negative cases. 
Time to detection was defined as the number of days from sample 
processing (day 1) to identification of positivity. Our results of MODS 
culture showed that the median time for culture positivity and drug 
susceptibility testing were 9 days (range 5 to 17 days for culture and range 6 
to 14 days for drug susceptibility testing). Our results are similar to those 
reported by Ejigu et al. (9 days).
69
 The median time to culture  positivity and 
drug susceptibility testing in the study of Moor et al. 
155
 and of Limaye et al. 
129
 were 7 days  and 10 days, respectively. Our results confirm a greater 
sensitivity and speed of detection with MODS culture in comparison to the 
gold standard of Lowenstein-Jensen culture as predicted on the basis of 
previous studies.
35,156,53,129,69 
Contamination is a common problem with all liquid cultures and 
MODS is not an exception; careful manipulation and rigorous aseptic 
technique must be maintained to minimize contamination. In the present 
study, contamination with fungi and other bacteria was 17.4%, higher than 






). The MODS assay was 
recently set up in our laboratory for the first time for tuberculosis confirmation 
and drug susceptibility testing. It is possible that the lack of previous 
experience may have caused the relatively high rate of contamination. 
Michaelet et al., have also reported that more extensive training and 




In the present study, among 153 culture-positive samples, the 
proportion of M. tuberculosis strains demonstrating sensitivity to all tested 
antibiotics (INH, RIF, STR and EMB) was 107 (69.9 %) and any drug 
resistance was 46 (30.1%). One drug resistance was observed in 30 strains 
(19.6%):  INH 3.9%  RIF 11.8%, STR 2.0% and  EBM 2.0%. Multidrug 
resistant M. tuberculosis as defined by WHO (resistant to RIF and INH)was 
observed in 8.5%. There were 9.2% of isolates showing resistance to two or 
more drugs. It is well known that there are large variations of the resitance 
percentages according to geographical areas and socio-economical conditions. 
In a similar study by Moor et al.
155
 done in Peru multidrug resistance was 
10.1%  and resistance to single drugs were as following: INH, 19.5%, RIF, 
10.7%, EMB, 10.1%, STR, 21.4%. The percentage of samples showing 
agreement between MODS culture and the gold-standard methods was 100% 
for RIF, 96.7% for INH, 98.8% for multidrug resistance, 95.4% for EMB, and 
91.7% for STR. 
In our study, there was a statistically significant difference of drug 
resistance between the two groups of patients. The proportion of strains 
resistant to any drug, to INH, multidrug resistance and ≥ 2 drugs in the group 
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of previous TB patients was higher than in the group of new tuberculosis 
suspected patients (p<0.01). However, there was no significant difference of 
resistance to RIF alone between the two groups of patients and this may be 
due to the longer exposure to anti-mycobacterial drugs of the previous TB 
patient group. Unfortunately, resistance to EMB and STR could not be  
determined in the group of previous TB patients due to the limited number of 
strains. 
The growing problem of drug resistance in M. tuberculosis is 
accompanied by increasing demand for quick, cheap, and easy techniques to 
detect resistance.
268
 Several methods to detect drug resistance are available, 
but none clearly satisfies the demand for quick, cheap and easy testing. 
Traditional agar-based methods can take months for results. Commercial 
drug susceptibility testing with liquid culture decreases turnaround times but 
requires expensive equipment. Molecular detection of gene mutations 
associated with drug resistance has also been developed, with variable 
sensitivity reported especially for in-house methods.
148
 
The MODS assay is a rapid, sensitive, specific direct method for 
simultaneous culture detection and drug susceptibility of M. tuberculosis 
9,155,156
 and was only recently introduced in our laboratory, therefore our 
results are still limited and difficult to compare with those of other groups. 
More work is needed to increase the patient sample and reach statistically 
significant numbers. 
 
6.2. The proportion of detected tuberculosis by using the PCR assay and 
the rate of M. tuberculosiss trains which do not harbor insert sequence 
IS6110 
 
A total of 480 clinical samples of patients with suspected tuberculosis  
including sputum, bronchial lavage, pleural fluid, cerebral spinal fluid (CSF), 
and others (gastric fluid, joint fluid, blood, abscess) were examined. Sputum 
was the most common type of specimen (76%). Positivity with  AFB 
staining was in 192 samples (40% of all types). No CSF specimen was 
positive with AFB. The AFB positivity was detected in approximately 50% 
of the sputum specimens (186/365) and in lower percentage in bronchial 
lavage (1/30 - 3.3%), pleural fluid (2/50 - 4 %) and other specimens (3/25 - 
12%). 
The 16S rDNA PCR assay for 480 clinical samples detected 258 
positive cases (53.8%). A 3.6 % (7/192) of  AFB-positive samples were 
negative. Furthermore the 16S rDNA PCR detected 73 cases (25.3%) of 
tuberculosis in AFB-negative samples, of which 54 (30.2%) were from 
sputum and  19 (17.4%) from the other type of specimens. 
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In previous studies, different amplification methods (PCR as well as 
isothermal) have been found to be positive in 95-100% of smear/culture 
positive specimens whereas the positivity ranges from 40-60% in smear 
negative paucibacillary pulmonary disease.
107 
According to Katoch et al.
107
 PCR methods for detection of M. 
tuberculosis from clinical specimens represent the ultimate in sensitivity and 
under optimum conditions are expected to detect 1-10 organisms. In this 
study, the 16S rRNA gene target is amplified by using a pair of unlabeled 
Mycobacterium genus specific PCR primers and a M. tuberculosis species-
specific TaqMan probe, meaning that all 258 samples positive with the16S 
rDNA PCRwere infected with M.tuberculosis. The 73 cases, negative with 
AFB, which were detected by this PCR assay indicated its useful role inearly 
confirmation of diagnosis in paucibacillary diseases. Futhermore the 16S 
rDNA PCR found that 7 cases among 192 AFB-positive samples (3.6%) 
were nontuberculous mycobacteria.  
Among the first proposed genomic targets for tuberculosis diagnostic 
PCR was the insertion element IS6110 which, being present in multiple copies 
(from 4 to 20 in more than 95% of M. tuberculosis strains), appeared to have 
the potential for an enhanced sensitivity.
177
Using a nested PCR assay protocol 
for the IS6110 target could further increase sensitivity of PCR. 
The results of a Yuen‟s study 270demonstrate that IS6110 is not present 
in the genome of all strains of M. tuberculosis and that the deletion of IS6110 
would occurs more frequently in the group of Vietnamese patients. 
In our study, the performance of IS6110 PCR assay was assessed in a 
total of 258 samples positive with 16S rDNA PCR. The result indicated that 
most of processed samples (98.8%) were positive with the IS6110 PCR (only 
3 samples corresponding to 1.2 %, were negative). This showed that the 
proportion of deletion of IS6110 sequence in M. tuberculosis strain in our 
study is lower than that in the above study. 
PCR has the potential to provide a more rapid, sensitive, and specific 
diagnostic assay for M. tuberculosis in clinical specimens.
30,68
 The IS6110 
nested PCR is an in-hous kit, performing in a conventional thermal cycler, so 
that this assay can be applied more widely than realtime PCR for the 16S 
rRNA gene. In case of using IS6110 PCR assay, results may be false-
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6.3. The distribution of genotypes of isolated M. tuberculosis strains and 
the association between the genotypes and drug susceptibility 
In the present study, EAI genotypes were seen in 65.6% of isolates, of 
which 15.6 % were of the EAI4-VNM genotype, and 46.7 % were of EAI5. 
This analysis indicates a dominance in Central Vietnam of the M. tuberculosis 
EAI family, with a strong supremacy of the EAI5 spoligotypes.  
Previous studies showed that the EAI lineage is more prevalent in 
South-East Asia, particularly in the Philippines(73%), in Myanmar and 
Malaysia (53%), in Vietnam and Thailand (32%). In this family, specific 
variants have been described for Vietnam (ST139 or EAI-4).
27
 EAI family 
represents an “ancient” strain type in some classification schemes, whereas 
the Bejing genotype is classified as “modern.” It is likely that this genotype 
was circulating in Vietnam prior to the introduction of the Beijing genotype 
and that East Asian Indian (EAI) clade genotypes represent the endemic M. 
tuberculosis strains, circulating in all age groups, while the Beijing 
“epidemic” strain has been relatively recently introduced or achieved 




In our study, Beijing genotype was observed in 12.3 % of isolates. 
Dang Duc Anh et al. reported in a previous study that Beijing genotypes 
represent approximately 40% of M. tuberculosis strains and are apparently 
endemic and stable in the community.
51
 In a more recent study of Nguyen van 
Hung et al.
167
, Beijing genotype was identified overall in Vietnam in 35.1% of 
isolates, and there was statistically significant difference of the distribution of 
Bejing genotype in the three regions of Vietnam (P < 0.01): in the South, 39%, 
in the North, 30.1%, and in the Centre, 28.6%. Our result indicated a lower 
proportion of Beijing genotype, however, because our sample sized was small, 
it may not be fully representative of all M. tuberculosis strains in central 
Vietnam. 
The association of the Beijing strain with drug resistance and MDR 
has been documented in other settings, though this has not been a consistent 
finding. It has been postulated that in much of Asia, non association is 
probably due to the endemic nature of the Beijing genotype, whereas in areas 
where the proportion of Beijing strains is increasing, and therefore is 
“epidemic”, associations with drug resistance are found.8 The association 
with drug resistance is particularly strong in Vietnam,
51
 unlike most parts of 
Asia. 
According to Nguyen van Hung et al.
167
 among new pulmonary 
tuberculosis patients, Beijing genotype with any-drug resistant tuberculosis 
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was 43.4% and MDR-TB was 5%. In a group of patients with recurrent 
pulmonary tuberculosis, Beijing genotype with resistance to any-drug was 
74% and MDR-TB was 26%. 
Sun et al.
224
 reported that the multidrug-resistant isolates (n = 41, OR 
2.66, 95%CI 1.28-5.50), rifampicin resistant isolates (n = 48, OR 2.88, 
95%CI 1.44-5.76), and streptomycin resistant isolates (n = 103, OR 3.35, 
95%CI 1.99-5.62) were more common among Beijing genotype strains than 
among non-Beijing strains, while streptomycin-resistant isolates were less 
common in East-African-Indian (EAI) genotype strains than in non-EAI 
strains (OR 0.30, 95%CI 0.14-0.64). 
In the present study, there was no significant association of the Beijing 
genotype with resistance to drug: 20 % of Beijing isolates and 28.9% of non 
Beijing isolates being resistant to any first-linedrug (OR = 0.6 [95% 
confidence interval {CI}, 0.2 to 2.3]; P=0.47); 6.7% of Beijing isolates and 
10.3% of non Beijing isolates being multidrug resistance (OR = 0.6 [95% 
confidence interval {CI}, 0.1 to 5.2]; P=0.66). 
Similarly, there was no significant association of the EAI genotype 
with resistance to drug:28.8 % of EAI isolates and 26.2% of non EAI isolates 
being resistant to any first-linedrug (OR = 1.1 [95% confidence interval 
{CI}, 0.5 to 2.6]; P=0.76); 8.6% of EAI isolates and 11.9% of non EAI 
isolates being multidrug resistance (OR = 0.7 [95% confidence interval {CI}, 
0.2 to 2.4]; P=0.58). 
In our study, however, the small sample (15 strains) of Beijing 
genotype cannot be considered a representative strain of Beijing genotype of 
M. tuberculosis in Central Vietnam; further analysis should be performed 
with a large sample.  
 
6.4. Molecular characteristics of the MTB_HUE_20 strain 
 
This is first time that a next generation sequencing for the whole 
genome of a mycobacterium was performed in Viet Nam. In “de novo” 
assembly process, we only assembled all reads to have the contigs, annotated 
all ORFs and made a full length genome with annotation on all loci. 
The full length of our strain is about 4,397KB, less than H37Rv strain, 
of 4,411KB. The diffrence in length is about 14KB. MTB_HUE_20 strain 
has only one copy of IS6110 versus 16 copies of H37Rv, each IS6110 is 
1355 bp in length (see Table A4 in appendix) and the lack of 15 copies of 
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Percentages of  A, T, C and G in genome of  the MTB_HUE_20 strain 
were similar to those of  H37Rv strain and of the other sequenced M. 
tuberculosis strains which are submitted on NCBI (BioProject). The 
MTB_HUE_20 strain contains a high percentage (64.8%) of G and C  
similar to that of H37Rv strain (65.6%) (table 15). 
Table15.  Statistics of complete genome M. tuberculosis H37Rv strain 
Base Frequency Percentage % 
A 758,565 17.2% 
C 1,449,985 32.9% 
G 1,444,603 32.7% 
T 758,379 17.2% 
GC 2,851,418 65.6% 
Length:             4,411,532 
 
Following the annotation of reference assembly, the MTB_HUE_20  
strain has 4062 genes and 4003 protein coding sequences, 3 rRNA genes and 
45 tRNA genes. This strain also has 2329 SNPs, 1257 of which lead change 
of amino acid and 159 DIPs, 105 of which  lead change of amino acid. 
After completing with the annotation of full length sequences, we will 
focus on analyzing the different genes in genome, such as genes for 
resistance, mobile elements, virulence genes, etc. 
As in most bacteria, various mobile genetic elements (MGEs) or 
„jumping genes‟ have been detected in the M. tuberculosis genome.87 These 
elements are capable of moving from one chromosomal location to another in a 
process called transposition and their dynamic nature has been implicated in the 
phenotypic characteristics of several pathogenic bacteria.
179,28
 Due to its 
extensive numerical and positional polymorphism in M.tuberculosis, the mobile 
genetic elements known as IS6110 has been used extensively as a genotypic 
marker in epidemiological studies.
142 
The insertion element IS6110 is present in multiple copies (from 4 to 
20) in more than 95 % of M. tuberculosis strains
177
. Yuen et al.
270
 reported 
M. tuberculosis isolates from Vietnamese patients have an average of 8 ± 7 
copies of IS6110.  
Comparing the whole genomic DNA of MTB_HUE_20 strain with that 
of  H37Rv strain, we determined it harbors only one copy of IS6110 versus 16 
copies of IS6110 in genome of H37Rv strain. MTB_HUE_20 strain was also 
confirmed positive with IS6110 PCR. 
An unusual feature of M. tuberculosis in Vietnam is the presence of a 
second highly prevalent spoligotype, ST319, or the Vietnam genotype.
51
 This 
genotype has a single IS6110 copy; it represents around 20% of the isolates 
from southern Vietnam. Although the MTB_HUE_20 strain has only one 
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IS6110 copy, has not the same spoligotype pattern as the Vietnam genotype 
or any spolygotype pattern of the updated international spoligotype database 
of the M.tuberculosis complex - SpolDB4. 
Rifampicin (RIF) is an important component in treating tuberculosis. 
It is a broad spectrum rifamycin derivative that interferes with the synthesis 
of mRNA synthesis by binding to the ß subunit of RNA polymerase (rpoB) 
in bacterial cells. The RIF binding site is a pocket in the upper wall of the 
main channel for double-stranded DNA entry just upstream of the 
polymerase catalytic center. The various RIF-resistant mutations are 
clustered around this pocket.
273
 Mutations of the rpoB gene are found in 
nearly all of the RIF resistant strains (>95%).
272
 
Comparing our result with the locus Rv0667 of rpoB gene of 
M.tuberculosis H37Rv,the percent of homology between 2 sequences is 
~99.98%, with 1 nucleotide different at position 3225, C in the MTB_HUE_20 
strain versus T in H37Rv. Translation of rpoB sequence of our strain to protein 
and alignment with 2possible amino acid sequences shows that the percent of 
homology of amino acid is 100%. Amino acid at position 1075 is alanine on both 
sequences.  
When doing alignment of rpoB sequence of the MTB_HUE_20 strain 
with partial CDS of rpoB sequence of two MDR M. tuberculosis strains (MDR-
TB2 and 331122070013) with mutation in rpoB gene, we found that there are 2 
different nucleotides at position 1333 and 1334. Protein alignment of 4 
sequences showed difference at position 445 of 1 amino acid: histidine (H) in 
the MTB_HUE_20 and H37Rv and arginine (R) in MDR-TB2 strain and 
aspartic (D) in strain 331122070013. 
Although the MTB_HUE_20 strain has one nucleotide at position 
3225 in rpoB gene which differs from strain H37Rv, the percent of 
homology of amino acid is 100%. Amino acid at position 1075 is alanine (A) 
on both sequences. Conversely, two above MDR strains differ from H37Rv 
one amino acid at position 1075. This indicated that there is no mutation on 
rpoB gene in the MTB_HUE_20 strain. As reported above, the 
MTB_HUE_20 strain is a MDR strain and less than 5% of resistant strains 
do not show a mutation in the rpoB resistance region.
134,192
 Pierre-Audigier et 
al.
182
 showed rare inconsistencies of mutated Mtb strains,  one of them may 
be clinically resistant, which could suggest other mechanism for resistance. 
One of them may even be clinically resistant, which could suggest greater 
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Isoniazid (INH) has been one of the most effective and specific agents 
for treating M. tuberculosis infections. It is a simple structure made up of a 
pyridine ring and a hydrazide group, two essential components to its 
powerful activity against M. tuberculosis.
272
 It has one of the most complex 
modes of action among all antibiotics. INH is a prodrug that requires 
activation of the catalase-peroxidase enzyme (KatG) coded by the katG gene. 
There are many molecular mechanisms causing INH resistance, but only 
some of them have been characterized.
251
 
Mutations in the katG gene, which hinder activation of the INH 
prodrug, are among the most frequent in INH-resistant strains: 20 to 95% 
INH-resistant strains have at least one mutation in the katG gene; its position 
varies according to their geographical origin.
92,102,188,192,272,274
  
In the present study, we performed alignment with locus_tagRv1908c 
of reference genome NC_000962.2 (Rv1908cis locus of katG gene of 
M.tuberculosis H37Rv) and INH-resistant M.tuberculosisstrain H0169/93. 
The percent of homology of 3 sequences is ~99.96%, with 1 nucleotide 
different at position 1388, T in the MTB_HUE_20 and H0169/93 strain 
versus G in H37Rv strain. Protein alignment of the 3 sequences showed 1 
amino acid different at position 463: Leucine (L) in both of MTB_HUE_20 
and H0169/93 strains versus  Arginine (R) in H37Rv strain. 
The MTB_HUE_20 strain is MDR resistant, this is consistant with the 
analysis of mutation of katG gene. 
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The MODS assay is a rapid, sensitive, specific direct method for 
simultaneous culture detection and drug susceptibility of M. tuberculosis, we 
will continue to research and improve the routine procedure of MODS assay 
at Carlo Urbani Centre, in Hue College of Medicine and Pharmacy. 
PCR is a more rapid, sensitive, and specific diagnostic assay for M. 
tuberculosis in clinical specimens. The IS6110 nested PCR is an in-hous kit, 
performing in a conventional thermal cycler, so that this assay can be applied 
more widely than the 16S rDNA realtime PCR. In case of using IS6110 PCR 
assay, results may show a low proportion of false negative. Combining 16S 
rDNA PCR with the IS6110 based PCR allowed detection of deletion of 
IS6110sequence in a limited number of M. tuberculosis isolates. 
Our results of spoligotype were inconsistent with those of previous 
studies indicating that spoligotyping should be performed with a large size of 
sample to determine the association between genotype and drug resistance of 
M. tuberculosis. 
Whole genomic DNA sequence of the MTB_HUE_20 strain should be 
completed with the annotation of full length sequences and with focus on 
analyzing different group of genes such as those involved in resitance, 
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Appendix 1: Media and buffers 
 
Reagents for Ziehl-Neelsen staining 
- Fuchsin solution 
 Fuchsin 
 Basis fuchsin   3g 
 95% ethanol (technical grade) 100ml 
  Dissolve basis fuchsin in ethanol………….Solution 1 
         Phenol 
Phenol crystals   5g 
Distilled water   100ml 
  Dissolve phenol crystals in distilled water 
  (gentle heat)……………………………….Solution 2 
Working solution: combine 10ml of solution 1 with 90ml of solution 2.  
 
- Decolorising reagent: 3% acid-alcohol 
Concentrated hydrochloric acid (technical grade)   3ml 
  95% ethanol (technical grade)    97ml 
- Counterstain: Methylene blue 
  Methylene bleu chloride     0.3g 
  Sterile distilled water            100ml 
Reagents for sputum decontamination 
- N-acetyl-L-cysteine-sodium hydroxide 
Solution A: NaOH 4% 
NaOH     4 g 
Distil- led water   100 ml 
Solution B: sodium citrate 2.9% 
sodium citrate 2 H2O  2.9 g 
distilled water    100 ml 
 Mix equal parts of solution A and solution B. Distribute in screw-cap 
flasks. Autoclave at 121 °C for 20 minutes. On the day of use, add N-
acetyl-L-cysteine at 1% concentration in the flask.  
- Phosphate Buffered Saline (PBS) 
10x PBS Solution  (Biobasis) 
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Reagents for Microscopic Observation Drug Susceptibility (MODS) assay 
 
- Middlebrook 7H9 liquid medium with casitone and glycerol (7H9) 
Middlebrook 7H9  broth base (Becton Dickinson)    5.9 g 
Glycerol (Sigma, St Louis, MO, USA)   3.1ml 
Casitone (Becton Dickinson)       1.25g 
Sterile distilled water     900ml 
- OADC (Becton Dickinson) 
- PANTA (BBL MGIT PANTA, Becton Dickinson)  
 










Final concentration in 
the well with sample 
and 
7H9-OADC media 
Polimixin B 6000 units 2000 units /ml 40 units/ml 
Amphotericin B 600 µg 200 µg /ml 4 µg/ml 
Nalidixic acid 2,400 µg 800 µg /ml 16 µg/ml 
Trimethoprim 600 µg 200 µg /ml 4 µg/ml 
Azlocillin 600 µg 200 µg /ml 4 µg/ml 
 
- Antibiotic solutions 
Isoniazid stock (0.1 mg/ml) 
 Isoniazid (Sigma)   1mg 
Sterile distilled water  10ml 
 
 Rifampicin stock  (1 mg/ml) 
 Rifampicin (Sigma)  10mg 
 Dimethyl sulphoxide    5 ml 
Sterile distilled water    5ml 
Streptomycin stock  (2 mg/ml) 
 Streptomycin (Sigma)  20mg 
 Sterile distilled water  10ml 
Ethambutol stock  (2.5 mg/ml) 
 Ethambutol (Sigma)  25mg 
 Sterile distilled water  10ml 
 
Working solutions of each drug are prepared on the day of use from 
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Dilution of stock in 
7H9-OADC to 
generate stock 2 
Dilution of stock 2 




in well when added 
to sample (µg/ml) 
























100 µl stock / 
900 µl 7H9-OADC 
(10 µg/ml) 
 
400 µl stock / 
600 µl 7H9-OADC 
(40 µg/ml) 
 














































































































Reagents for DNA extraction  
- DNeasy Blood & Tissue kit (Qiagen) for extraction of DNA from clinical 
samples. 
- Reagents for extraction of DNA from isolated mycobacterial strains by 
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+ Glycine stock 10% (wt/vol) 
+ Sodium dodecyl sulfate (SDS) 10% 
+ Proteinase K 10 mg/ml (Sigma) 
+ NaCl 5 M 
+ Chloroform-isoamyl alcohol (24:1) 
+ GTE Solution 
  Tris-HCl (pH 8.0)    25 mM 
  EDTA    10 mM 
  Glucose    50 mM 
+ Lysozyme Solution 
For optimal lysozyme activity, make a fresh 10 mg/ml solution of lysozyme 
(Sigma) in 25 mM Tris-HCl (pH8.5). 
+ CTAB Solution (Sigma) 
Sodium cloride  4.1 g 
distilled water   90 ml   
Cetrimide    10 g  
      (Cetrimide is hexadecyltrimethylammonium bromide; Sigma) 
 
Reagents for PCR assay 
- PCR Master Mix (2X) (Fermentas) 
- Two sets of primers for the IS6110 based nested PCR assay (following the 
protocol of tuberculosis laboratory of Section of Experimental and Clinical 
Microbiology, Department of Biomedical Science, SassariUniversity): 
 + External primers: 
IS1:  5- GCA  CCG  CCC  GGG  ACC -3‟ 
IS2: 5- CTG  CCC  AGG  TCG  ACA  CAT  AG -3‟ 
+ Internal primers:  
IS3:  5‟- GAT  GGT  TTG  CGG  TGG  GGT  GTC  GAG  T-3‟ 
IS4: 5‟- GAT  CGT  GGT  CCT  GCG  GGC  TTT  GC-3‟ 
- Tris-Borate EDTA buffer: TBE 10X buffer (Bio Rad). 
- Loading 6X (Fermentas) 
- GeneRuler™ 100 bp DNA Ladder (Fermentas) 
- Agarose 2% 
- LightPower iVAMTB rPCR Kit (VietA company, Vietnam) for 16S rDNA 
sequence based realtime PCR. 
Reagents for Spoligotyping 
- Spoligotyping kit for detection of the M.tuberculosis complex of Ocimum 
Biosolutions. This kit contains: 
 + One activated Biodyne C membrane - to which oligonucleotides 
derived from the known spacers in the DR cluster are covalenttly linked in 
parallel line. 
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• Primer DRa (biotinylated at 5‟ end):  
5‟ -GGT  TTT GGG TCT GAC GAC- 3‟ 
  • Primer DRb: 5‟ -CCG AGA GGG GAC GGA AAC- 3‟ 
+ Positive control 1(M. tuberculosis strain H37Rv) 
+ Positive control 2 (M. bovis BCG P3)  
- Streptavidin - Horseradish Peroxidase 500U/ml (GE Healthcare) 
- ECL detection reagents (GE Healthcare) 
- Buffers 
+ 20X SSPE - Stock Solution 
0.2M Na2HPO4.2H20      35.6 g/L 
3.6M NaCl    210.24 g/L 
20mM EDTA         7.4 g/L 
 Demineralised water up to     1000 mL 
+ 10% SDS  
SDS           10g   
Demineralised water up to      100 mL 
 + 2X SSPE/0.1% SDS 
20X SSPE   100 mL 
10% SDS     10 mL 
DW     890mL 
 + 2X SSPE/0.5% SDS 
20X SSPE   100 mL 
10% SDS     50 mL 
Demineralised water  850mL 
 + 2X SSPE 
20X SSPE   100 mL 
Demineralised water  900mL 
 + 1% SDS  
10% SDS   100mL      
Demineralised water  900 mL 
 + 20 mM EDTA, pH8 
EDTA         7.4g 
Demineralised water up to   1000Ml 
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Appendix 2: Spoligotype of M.tuberculosis isolates in Central Vietnam 
 
Table A3:  Spoligotype of M.tuberculosis isolates in Central Vietnam 
 
no. Strain Spoligotype Description Binary   SIT No Spoligotype 
1 13 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
2 28 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
3 29 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
4 335 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
5 438 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
6 479 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
7 592 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
8 CM12 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
9 CT3 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
10 DN840 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
11 DN846 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
12 DN858 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
13 DN867 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
14 DN955 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
15 DN970 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■■■■■■■ 1 BEIJING 
16 DN922 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□■■■■■■■ 1378 CAS 
17 406 ■■■■■■■■■■■■■■□■■■■■■■■■■■■■□□□□■□■■□■■□■■■ 303 EAI1_SOM 
18 535 ■■■■■■■■■■■■■■□■■■■■■■■■■■■■□□□□■□■■□■■□■■■ 303 EAI1_SOM 
19 CM14_2 ■■■■■■■■■■■■■■□■■■■■■■■■■■■■□□□□■□■■■■■□■■■ 1251 EAI1_SOM 
20 DN769 ■■□■■■■□□□□□□□□□□□□□□□□□□■■■□□□□■□■■■■■■■■■ 89 EAI2_NTB 
21 12 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
22 376 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
23 381 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
24 526 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
25 558 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
26 852 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
27 CM22 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
28 16 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
29 261 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
30 301 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
31 350 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
32 470 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
33 CM2(2) ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
34 CT4 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
35 DN750 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
36 DN796(1) ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
37 DN15(NA) ■■■■■■■■■■■■■■■■□■■■■■■■■□□■□□□□■□■■■■■■■■■ 1571 EAI4_VNM 
38 PK31 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■■■■■ 139 EAI4_VNM 
39 PK4 ■■■■■■■■■■■■■■■■■■■■■■■■■□□■□□□□■□■■■■■□□■■ 456 EAI4_VNM 
40 5 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
41 21 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
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no. Strain Spoligotype Description Binary   SIT No Spoligotype 
42 23 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
43 25 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
44 26 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
45 30 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
46 33 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
47 34 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
48 37 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
49 131 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
50 269 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
51 276 ■■■■■■■■■■□■■■■■■■■■■■■■■■■■□□□□■□■■□■■■■■■ 1726 EAI5 
52 285 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
53 288 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
54 313 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
55 318 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
56 322 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
57 361 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
58 372 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
59 386 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
60 397 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
61 414 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
62 416 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
63 419 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
64 451 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
65 480 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
66 561 ■■■■■■■■■■■■■■■■■■□□■■■■■■■■□□□□■□■■□■■■■■■ 1573 EAI5 
67 572 ■■■■■■■■■■■■□■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 617 EAI5 
68 280 ■■■■■■■■■■■■□■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 618 EAI5 
69 555 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
70 BT6 ■■■■■■■■■■■■□■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 617 EAI5 
71 CM17 ■■■■■■■■■■■■■■■■■■□□■■■■■■■■□□□□■□■■□■■■■■■ 1573 EAI5 
72 CM18 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
73 CM20 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
74 CM21 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
75 DN819 ■■■■■■■■■■■■■■■■■■□□■■■■■■■■□□□□■□■■□■■■■■■ 1573 EAI5 
76 DN874 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
77 DN923 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 236 EAI5 
78 PK1 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
79 PK16 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
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no. Strain Spoligotype Description Binary   SIT No Spoligotype 
80 PK19 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
81 PK3 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
82 591 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
83 599 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
84 527 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
85 CM14 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
86 CM25 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
87 CT2 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
88 DN745 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
89 DN861 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
90 DN974 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
91 BM11 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
92 CM10 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
93 CM15 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
94 DN10 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
95 DN865 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
96 DN870 ■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■ 152 EAI5 
97 DN67 □■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 472 H3 
98 531 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■□□ 748 H3 
99 CM3 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 50 H3 
100 302 ■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□■□■■■■■■■■■ 937 MANU1 
101 565 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■■■■■■■■■ 100 MANU1 
102 BM9 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□■■■■■■■■■ 1247 MANU2 
103 8 ■■■■■■■■■■■□■□□□□□□□□□□□■■■■■■■■□□□□■■■■■■■ 249 T1 
104 18 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 53 T1 
105 463 ■■■■■■■■■■■■■■■■■■■□■■■■■■■■■■■■□□□□■■■■■■■ 120 T1 
106 597 □■■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 1645 T1 
107 DN63 ■□■■■■■■■■■■■■□■■■■■■■■■■■■■■■■■□□□□■■□■■■■ 1317 T1 
108 461 ■■■■■■■■■■■■■■■■■■■■■■■■□□□■■■■■□□□□■■■□■■■ 942 T2 
109 3 ■■■■■■■■■■■■■■■■■■□□□□□□□■□□□□□□□□□□□□□□□■■ 619 U 
110 24 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■■■ 458 U 
111 27 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■■■ 458 U 
112 286 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■■■ 458 U 
113 404 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■■■ 246 U 
114 415 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■ 523 U 
115 547 □□□□□□□□□□□□□□□□■□□□□□□□□□□□□□□□□□■■■■■■■■■ 1184 U 
116 CM16 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■■■ 458 U 
117 CM9 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■■■■ 1338 U 
118 DN815 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■■■■ 458 U 
119 MTB_HUE_20 ■■■□□□□■■■■■■■■■■■■■■■■■■■□■□□□□■□■■■■■■■■■  Unk 
120 278 ■■■■■■■■□□□□□□■■■■■■■■■■■■□■□□□□■□■■■■■■■■■  Unk 
121 289 ■■■■■■■■■□■■■■■■■■■■■■■■■■■□□□□□□□■■■■■■■■■  Unk 
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Appendix 3: Insertion sequence IS6110 in genome of H37Rv 
 




Name Type Region 
IS6110-1, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element 889021..890375 
IS6110-2, len: 1355 bp. 
Almost identical toInsertion 
sequence IS986 element. 
mobile_element complement(1541952..1543306) 
IS6110-3, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element complement(1987703..1989057) 
IS6110-4, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element 1996101..1997455 
IS6110-5, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element 2365414..2366768 
IS6110-6, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element complement(2430117..2431471) 
IS6110-7, len: 1355 bp. 
Insertion sequence IS6110. 
mobile_element 2550014..2551368 
IS6110-8, len: 1355 bp. 
Insertion sequence IS6110 
mobile_element 2635577..2636931 
IS6110-9, len: 1357 bp. 
Insertion sequence IS6110. 
mobile_element complement(2784614..2785970) 
IS6110-10, len: 1355 bp. 
Insertion sequenceIS6110. 
mobile_element 2972109..2973463 
IS6110-11, len: 1375 bp. 
Insertion sequenceIS6110. 
mobile_element complement(3120523..3121897) 
IS6110-12, len: 1355 bp. 
Insertion sequenceIS6110. 
mobile_element 3551230..3552584 
IS6110-13, len: 1355 bp. 
Insertion sequenceIS6110. 
mobile_element 3552713..3554067 
IS6110-14, len: 1355 bp. 
Insertion sequenceIS6110. 
mobile_element 3710382..3711736 
IS6110-15, len: 1355 bp. 
Insertion sequenceIS6110 
mobile_element 3795058..3796412 
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FOR SAMPLE COLLECTION AND INTERVIEWING 
 
Study title: Molecular epidemiology and phenotypic and genetic 
characterization of mycobacteria Isolated in central Vietnam. 
Research Team Contacts 
Ngo Viet Quynh Tram, Dr, Msc 
PhD student, Sassary University , Italy 
Lecturer, Department of Microbiology          
HueCollege of Medicine and Pharmacy 
Hue, Vietnam 
Phone: +84 914202317 
Nguyen Thi Chau Anh, Dr 
 
Lecturer, Department of 
Microbiology          
HueCollege of Medicine and 
Pharmacy 
Hue, Vietnam 
Phone: +84 984570083 
This study is being taken as part of PhD of Ngo viet Quynh Tram, the 
principal investigator of this study, with the guidance and supervision of 
researcher from SassaiUniversity (Prof. Piero Capuccinelli). 
This study aims to identify Molecular epidemiology and phenotypic and 
genetic characterization of mycobacteria Isolated in central Vietnam. Your 
participation in this study is voluntary. Your refusal to participate will not 
affect your diagnosis and treatment in any way. If you agree to participate in 
this study, you can withdraw from your participation at any time during the 
interview with no comment or penalty. 
If you agree to participate, we will take your specimens (such as sputum or 
bronchial lavage, etc.) for for study on M.tuberculosis and you will be asked 
to answer some questions about tuberculosis. The questions will be about 
history of tuberculosis, its symptoms and treatment. 
Information provided will be treated confidentially and we will not identify 
you in any of our publications or reports. What we learn from you will be 
used as the basis of our university research project. The Ethics Committee of 
Hue College of Medicine and Pharmacy has provided formal ethics approval 
for this study. 
You are very welcome to ask us anything about what we are doing and what we 
are studying. Please contact the researcher team members named above to have 
any questions answered or if you require further information about the project.  
If there are issues related to the study and/or you would like to have further 
discussion on ethics issues, please contact A/Prof. Tran Van Huy, Head of 
Office for Research and International Relations, Level 3, Building A, Hue 
College of Medicine and Pharmacy, Phone number: 054 3822873.  
Thank you for your time and for helping us in our study. 
Ngo Viet Quynh Tram 
TECHNOLOGY & INNOVATION MANAGEMENT CENTRE 
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Attestation of Authorship 
 
 
I hereby declare that this submission is my own 
work and that, to the best of my knowledge and belief, 
it contains no material previously published or written 
by another person nor material which to a substantial 
extent has been accepted for the qualification of any 
other degree or diploma of a university or other 
insititution of higher learning, except where due 
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Many people and organizations contributed to the completion of my 
PhD study and are too numerous to name although I acknowledge the 
contribution and assistance provided by everyone. Specifically I would like to 
express my sincere gratitude and appreciation to the following people and 
organizations that enabled me to study in Italy and Vietnam, and for the 
ideas and suggestions given to me during the research process. 
Foremost, I would like to express my sincere gratitude to my 
supervisor Professor Piero Cappucinelli for the continuous support of my 
PhD study and research, for his patience, motivation, enthusiasm, and 
immense knowledge.  His constant inputs both in Italy and in Vietnam have 
helped to progress my studies and thesis writing. I could not have imagined 
having a better advisor and mentor for my PhD study. 
I would like to thank Professor Giovanni Delogu for his expertise and 
kindness. His invaluable constructive advice and assistance with the 
methodology help me to perform this study. 
I would like to express my sincere thanks to Professor Bruno Masala 
who facilitated my attendance to the PhD program at Sassari University. 
 I owe Hue College of Medicine and Pharmacy and Department of 
Microbiology for their support across the studying process, making things 
happen to ensure the success of my work. 
I would like to acknowledge the scholarship and the generous financial 
contribution received from the Government of Italy grant through the 
managers of the Carlo Urbani Project, Dr. Stefano Ferroni and Dr. Le Van 
An who facilitated my research in the laboratory of Carlo Urbani Centre.  
I equally appreciate the support provided by the staff of the 
tuberculosis laboratories of the section of Experimental and Clinical 
Microbiology, Department of Biomedical Science at Sassari University, the 
Institute of Microbiology at Catholic University of Sacred Heart, Rome in 
Italy and the Department of Microbiology at National Lung Hospital in 
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